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ABSTRACT 
Lyme borreliosis is an emergent threat to human health. It is estimated that 300,000 
cases of Lyme disease are diagnosed annually in the United States. In recent years, non-
traditional areas are starting to report more and more cases. While much research has gone 
into the tick and bacteria responsible for the disease, frequently new Borrelia species are 
being described and implicated in human illness. These species often go unstudied, and their 
threat to human health is not known. In the hopes of closing knowledge gaps on Lyme 
borreliosis in the US, we surveyed a non-endemic state, Louisiana, for Lyme Borrelia in 
ticks and mammals. We also assessed the potential for a second North American Lyme 
Borrelia species to cause mammalian disease by examining the infectivity and immune 
response of a non-B. burgdorferi sensu stricto North American isolate, Borrelia bissettii, in a 
murine model. Similarities between B. burgdorferi ss and B. bissettii prompted us to assess 
the ability for Ixodes scapularis to acquire and transmit B. bissettii to susceptible animals. 
Our research uncovered evidence for an enzootic cycle of Borrelia burgdorferi ss at a site in 
Louisiana between small mammals and Ixodes scapularis ticks. This, combined with broader 
evidence of multiple tick-borne pathogens in human biting ticks, highlights the need for tick-
borne disease surveillance in areas not traditionally considered endemic. Borrelia bissettii 
may play a role in human disease in the US, especially in areas where B. burgdorferi ss is not 
common. We describe similarities between B. bissettii and B. burgdorferi ss murine 
infection; moreover, current Lyme diagnostic test could not differentiate infections. While I. 
scapularis could acquire B. bissettii spirochetes from infected mice, they existed at lower 
burdens compared to B. burgdorferi ss. Ixodes scapularis was also unable to transmit B. 
bissettii infection to susceptible animals, incriminating a different tick vector in the eastern 
xi 
 
and southern US. These data support the need for continued work on the Lyme Borrelia 
species as a whole, especially in non-traditional areas and on understudied organisms. 
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CHAPTER 1. INTRODUCTION AND LITERATURE REVIEW 
1.1. General Borreliology 
In this section, information is presented that describes the characteristics of the 
bacteria within the Borrelia genus. More specifically information will be provided about the 
bacteria in the Borrelia burgdorferi sensu lato (sl) species complex (referred to as Lyme 
Borrelia) including basic biology and genetics. Following this overview, the current 
understanding of the Lyme Borrelia transmission cycle will be presented. While European 
and Asian Lyme Borrelia will be mentioned when relevant, focus will be on the Lyme 
Borrelia in North America. As such, the ecology and genetic diversity of North American 
Lyme Borreliosis will be described followed by a specific description and distribution of 
each of the Lyme Borrelia currently described in the United States. Next the mechanisms 
Lyme Borrelia utilize throughout infection in both the vector and vertebrate will be 
presented. Followed by the epidemiology of Lyme borreliosis in the United States and a 
review of the clinical disease caused by Lyme Borrelia infection including murine models of 
study and current methods in diagnostics. 
The genus Borrelia are within the family Spirochaetacea under the order 
Spirochaetales. Borrelia are gram-negative spirochete bacteria [3]. Like other spirochetes 
they are uniquely defined by their high motility and flat-wave morphology due to several 
periplasmic flagella [3]. The Borrelia spirochetes are also unique in that they have a double 
membrane, which classifies them as gram-negative bacteria, yet lack the classical 
lipopolysaccharide and instead produce a slew of outer membrane associated lipoproteins [4, 
5]. Spirochetes in the Borrelia genus share genetic similarities, which include a linear 
chromosomes ~900 kilobases in size which contains many housekeeping genes and is 
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conserved to gene composition and arrangement between Borrelia species [6]. Very unique 
to tis genus is the amount of plasmids these bacteria can harbor. To date, B. burgdorferi ss 
strain B31 has a recorded 21 plasmids [4]. Plasmids for these bacteria harbor many of the 
virulence and infection associated genes they also harbor many pseudogenes which are 
believed to be evidence of genetic decay. Surprisingly these plasmids can add an additional 
400-650 kilobases to the spirochete’s genome [7]. 
While the chromosome contains many housekeeping genes and is fairly conserved in 
regards to gene content and organization amongst the Borrelia spirochetes, the plasmids are 
highly variable and contain many psudo-genes and genes associated with virulence and the 
organism’s specific enzootic cycle [6-8]. Although similar in many aspects, the Borrelia 
genus can be further divided into two major groups: the Relapsing fever Borrelia and the 
Lyme Borrelia.  
1.1.1. Relapsing Fever Borrelia 
The majority of relapsing fever borreliae are transmitted by ticks from the family 
Argasidae, commonly referred to as the soft ticks [6]. A single relapsing fever Borrelia is 
strictly associated with a louse vector. Recently a group of Ixodidae, or hard-tick, associated 
relapsing fever Borrelia have also been described [6, 9]. The relapsing fever Borrelia group 
also contain newly recognized reptilian associated species [10].  These Borrelia are 
distributed worldwide and infect a variety of animals [6]. Some of the spirochetes have been 
shown to be horizontally transmitted between vector and host, and vertically from female tick 
to pyrogeny [11, 12]. Clinically the relapsing fever Borrelia cause a relapsing fever induced 
by spirochetemia. This is roughly characterized by an initial three-day fever followed by a 
seven day relapse and then another three days of fever, this cycle repeats multiple times, 
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hence the group’s name [13]. Louse borne relapsing fever was a disease of concern prior to 
the 17th century but is mainly eliminated today (except for areas of Africa) [14]. Tick borne 
relapsing fever is still a cause of human disease worldwide; however, case numbers pale in 
comparison to the Lyme Borrelia.  
1.1.2. The Lyme Borrelia (Borrelia burgdorferi sensu lato) 
Like relapsing fever Borrelia, Lyme Borrelia have been shown to infect many types 
of animals; however, they are only known to be transmitted by ticks from the Ixodidae family 
[15]. And while Lyme borreliae spirochetes most likely predate humans [16], Lyme 
borreliosis has only recently emerged as a significant cause of human morbidity [17]. 
Borrelia burgdorferi sensu stricto (ss) was first identified in 1982 [18]. Three decades later 
another 18 species of closely related spirochetes are now recognized to form the species 
complex, Borrelia burgdorferi sensu lato (sl) [19]. Members of this complex are distributed 
across the globe and have been identified on almost every continent (Figure 1.1). Twelve of 
Figure 1.1. Worldwide geographic distribution of Borrelia burgdorferi sensu lato genotypes [1]. 
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these spirochetes have been implicated in human illness, while pathogenicity of the six others 
is still unknown (Table 1.1). Currently seven species of B. burgdorferi sl have been described 
in the United States, yet only B. burgdorferi ss has widely been considered pathogenic to 
humans (Table 1.1). All the North American B. burgdorferi sl spirochetes are confirmed to 
be vectored by Ixodes genus ticks (Table 1.1). The vectoral capacity of other North American 
Ixodidae genera ticks has not yet been demonstrated.  
1.2. Lyme Borrelia in the United States 
Seven species of B. burgdorferi sl have been described in the United States. They are: 
Borrelia americana, Borrelia andersonii, B. burgdorferi ss, Borrelia bissettii, Borrelia 
californiensis, Borrelia carolinensis and Borrelia kurtenbachii. Borrelia burgdorferi ss is 
currently considered the only pathogenic Lyme Borrelia in the United States (Figure 1.2); 
however, evidence is growing that implicates more of these species in human illness (see 
probable pathogens [P] in Table 1.1). Here the ecology of Lyme Borrelia in the United States 
will be discussed followed by an overview of the current knowledge of each of the North 
American B. burgdorferi sl.  
1.2.1. Ecology of Lyme Borrelia 
Lyme Borrelia bacteria exist in enzootic cycles in nature. These cycles include vector 
ticks, reservoir animals and the bacteria itself. Many Borrelia have associations with certain 
vectors and specific enzootic cycles [15]. Because of these associations, the bacteria are often 
limited to hosts parasitized by the tick, which plays an important role in the bacterium’s 
lifecycle. Defining the ecology of Lyme disease is a Sisyphean task.  
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Species  
(type strain) 
Human 
Pathogen 
Distribution Host Main vector References 
for 
description 
B. afzelii (VS461) C Europe, Asia Apodemus spp., Myodes glareolus, Sorex spp., Sciurus 
spp., Erinaceus spp., Rattus spp. 
Ixodes ricinus,I. 
persulcatus,I. hexagonus 
[21] 
B. americana  
(SCW-41) 
P North America Thryothorus ludovicianus, Pipilo erythrophthalmus I. pacificus,I. minor [22] 
B. andersonii  
(21038) 
P North America Sylvilagus spp., (Passeriformes) I. dentatus [23] 
B. bavariensis  
(PBi) 
P Europe, Asia 
(?) 
Apodemus spp., Myodes spp., Microtus spp. I. ricinus,I. persulcatus(?) [24] 
B. bissettii  
(DN127-cl9-2) 
P North 
America, 
Europe 
Neotoma spp., Peromyscus spp., Sigmodon spp., EU: 
unknown 
I. pacificus,I. scapularis,I. 
spinipalpis,I. affinis,I. 
minor,EU: unknown 
[25] 
B. burgdorferi  
(B31) 
C North 
America, 
Europe 
Peromyscus spp., Tamias spp., Neatoma spp., Sorex 
spp.,Sciurus spp., Sigmodon spp., Erinaceus spp., Rattus 
spp., Procyon lotor, Turdus migratorius 
I. ricinus,I. hexagonus, I. 
scapularis,I. pacificus,I. 
affinis,I. minor,I. 
spinipalpis,I. muris 
[26] 
B. californiensis  
(CA446) 
U Western US Dipodomys californensis Unknown [27] 
B. carolinensis  
(SCW-22) 
U Southeast US P. gossypinus, N. floridana Unknown (I. minor?) [28] 
B. finlandensis  
(SV1) 
U Finland, 
Norway 
Lepus timidus I. ricinus [29] 
B. garinii  
(20047) 
C Europe, Asia, 
Artic-Antarctic 
circles 
Turdus merula, T. philomelos, Parus major, seabirds 
(Puffin, Guillemot, Kittiwake, Razorbill) 
I. ricinus,I. persulcatus,I. 
uriae 
[30] 
B. japonica  
(HO14) 
P Japan Sorex unguiculatus, Apodemus spp., Eothenomys smithi I. ovatus [31, 32] 
Table 1.1. Currently recognized Borrelia burgdorferi sl species with their human pathogenic classification, distribution, known 
host species and tick vectors [1]. 
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Species  
(type strain) 
 
Human 
Pathogen 
 
Distribution 
 
Host 
 
Main vector 
 
References 
for 
description 
B. kurtenbachii  
(25015) 
P North 
America, 
(Europe?) 
Microtus pennsylvanicus, Zapus hudsonius Peromyscus 
spp.? 
Unknown (I. scapularis?) [2] 
B. lusitaniae  
(PoTiB2) 
C Mediterranean 
basin 
Lacertidae I. ricinus [33] 
B. sinica  (CMN3) U China Niviventer confucianus I. ovatus [34] 
B. spielmanii (PC-
Eq17N5) 
C Europe Glis glis, Eliomus quercinus I. ricinus [35] 
B. tanukii  
(Hk501) 
U Japan Apodemus spp., Clethrionomys rufocanus, Eothenomys 
smithii 
I. tanuki [36-38] 
B. turdi (Ya501) U Japan Turdus spp. I. turdus [36-38] 
B. valaisiana 
(VS116) 
C Europe, Japan Turdus merula, T. philomelos, Parus major I. ricinus,I. columnae [39] 
B. yangtze  (nd) U China Niviventer fulvescens, Apodemus spp. I. granulatus, I. nipponensis [40] 
Table 1.1. cont. 
*C=confirmed; P=probable; U=unknown 
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Many factors are known to contribute to the disease, and large ecological studies admit there 
are confounding unknown factors [20]. A general description of Lyme Borrelia ecology is 
best illustrated with the well-studied Northeastern B. burgdorferi sensu stricto-I. scapularis 
enzootic cycle. 
Ixodes scapularis, commonly known as the “black-legged tick”, are forest dwelling 
arthropods. They make use of the microhabitat found in the dense underbrush and leaf litter 
as they are highly susceptible to desiccation [41]. Once upper level environments are right, 
the tick climbs (quests) twigs, grass or plants and utilizes sensory organs (haller’s organs) to 
detect movement, heat, carbon dioxide with the ultimate goal of latching onto animals that 
pass by [42]. The tick requires three bloodmeals to complete its lifecycle, which is 
represented by four stages: the egg, larvae, nymph and adult. As one can imagine, availability 
of suitable hosts are essential for the lifecycle of the tick; this is also critical for the lifecycle 
Figure 1.2. Distribution of North American Lyme Borrelia [2]. 
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of the Borrelia spirochete. Borrelia burgdorferi sl spirochetes are not passed from mother to 
pyrogeny (transovarial); therefore, acquisition of the spirochete must come from an infected 
bloodmeal [12]. This requires susceptible and/or infected animals. Ixodes scapularis is a 
generalist parasite, meaning it will feed on a slew of different hosts, yet each life stage has a 
common host repertoire [43, 44]. For example, the larval and nymphal stages are more likely 
to be found feeding on small rodents (such as Peromyscus spp., mice) while the adults feed 
most often on deer [44]. This is important because it is believed that prior to major 
deforestation and subsequent devastation of natural deer populations, by hunting and habitat 
destruction by European settlers in the eastern US, both I. scapularis and Borrelia were 
widespread [45]. The emergence of Lyme is thought to coincide with the reforestation and 
deer population rebound in the 20th century and their close association with human 
populations [46]. These ideas are supported by experimental studies removing deer from 
Lyme endemic areas subsequently decreasing the abundance of infected ticks [47-49]. After 
deer populations rebounded, refugee population of I. scapularis and Borrelia “exploded” and 
today we have a Lyme epidemic. In areas like the Northeast US, small mammals 
(Peromyscus spp and Sorex spp) are the animal reservoirs for the Lyme bacteria [50]. 
Immature ticks (larva and nymph) feed on these animals and after molt are able to transmit 
the infection to other animals, perpetuating the cycle, or to humans, causing disease [50]. 
Humans are considered accidental and dead-end host for the bacteria. Borrelia does often 
exist in areas where major human vectors are not established or in low density. In these areas, 
the Borrelia spirochete is maintained in cryptic cycles, which involve reservoir animals and 
highly competent host-specific vector ticks (which rarely feed on humans) [51, 52]. These 
enzootic cryptic cycles perpetuate infectious Borrelia spirochetes; however, if a human biting 
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vector were to establish, the bacteria would eventually become epizootic and “spill out” into 
the human population causing illness. This is currently the case in many parts of North 
America [53, 54].  Active surveillance of vector tick populations and Borrelia prevalence in 
hosts and ticks is essential to understanding the evolving human risk in traditionally non-
endemic areas of Lyme disease. 
1.2.2. Genetic Diversity of Lyme Borrelia 
 Lyme Borrelia are genetically very fascinating. In 1997, the genome of Borrelia 
burgdorferi (B31 strain) became one of the first microbial genomes to be fully sequenced [5]. 
Since the advent of next generation sequencing, the total number of publically available 
genomes within the B. burgdorferi sl species complex at this time stands at eight complete 
(chromosomes & plasmids), three chromosomes (only), 14 plasmid profiles and another 66 
scaffold/contigs (http://www.ncbi.nlm.nih.gov/genome/?term=borrelia). The genome of 
Lyme Borrelia spirochetes all consist of a linear chromosome around 900 kilobases in size. 
This chromosome is highly conserved in both gene content and order between the different 
B. burgdorferi sl species; this is due to the fact it contains many essential housekeeping genes 
[55]. In addition to the chromosome, Lyme Borrelia spirochetes contain a repertoire of linear 
and circular plasmids ranging from 9 kb to over 50 kbs which can add up to an additional 600 
kbs of DNA [7]. Some strains contain up to 21 of these plasmids [7]. The plasmids 
themselves contain the majority of the genetically diverse genes, many of which are involved 
in the bacteria’s pathogenesis, tick-host lifecycle, and a host of pseudo-genes thought to be a 
sign of genetic decay [4, 7, 8]. As previously mentioned, the B. burgdorferi sl complex 
consists of 19 currently recognized species, seven of which have been identified in the 
United States. Multilocus sequence typing (MLST) and whole genome phylogenetics have 
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allowed for the delineation of the phylogenetic structure of the complex (Figure 1.3). This 
has immensely aided in the identification of shared and unique genes between and within 
species, which has ultimately facilitated in developing better diagnostic tests and identifying 
potential vaccine targets.   
1.2.2.a.Borrelia americana  
Spirochetes now recognized as B. americana were first isolated in 1993, by Schwan 
et al. from pools of adult I. pacificus [56]. The two isolates (CA-8-89, CA-29-91) were later 
determined by multilocus sequence analysis to represent an unknown species of Borrelia and 
temporarily named genomospecies 1 by Postic et al. [27]. In 1994, spirochetes (B. 
americana) were isolated from nymphal Ixodes minor ticks collected off Carolina wrens 
(Thryothorus ludovicianus) and Eastern towhees (Pipilo erythrophthalmus) in Charleston, 
South Carolina [57, 58]. It wasn’t until 2009 that the B. americana species was delineated 
after multiple strains were subjected to multilocus sequence analysis [22]. Like many of the 
North American Lyme Borrelia, little is known about this group of spirochetes. The bacteria 
has been detected in California and South Carolina, in I. minor and I. pacificus ticks [56, 57, 
59]. Its suggested reservoirs are birds and small mammals. Human pathogenicity is unknown; 
however, the organism has been detected in human clinical samples by molecular methods 
[60, 61]. To date no laboratory infection studies have been published. The type strain is 
SCW-41. 
 1.2.2.b.Borrelia andersonii 
Borrelia andersonii was first isolated in 1989 by Anderson et al. from Ixodes dentatus 
ticks and a rabbit kidney in New York [62]. Marconi et al. (1995) proposed the delineation of 
these isolates from B. burgdorferi ss by sequence polymorphisms in the rRNA genes, and 
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named the species after its discoverer Dr. John Anderson [23]. These conclusions were 
supported by Lin et al. (2001) when even more B. andersonii strains, which were isolated 
from ticks feeding on rabbits in Missouri, were added to the phylogenetic analyses [63].  
Borrelia andersonii has been identified in multiple tick species, including: Ixodes dentatus, 
Amblyomma americanum, I. scapularis and Haemaphysalis leporispalustris [23, 64]. 
Field work suggest the reservoirs for B. andersonii are cotton tail rabbits, birds and 
possibly lizards [23, 63, 65]. Borrelia andersonii has been detected in multiple states in the 
US (FL, SC, GA, MO, MI, NY) [15]. Only one study has assessed the ability of B. 
andersonii (termed B. burgdorferi ss in the paper). Anderson et al. found 0 of 3 mice to be 
culture positive for B. andersonii (Strain 48080) spirochetes [66]. The pathogenic potential of 
B. andersonii to humans is unknown; however, it has been molecularly detected in human 
clinical samples [60, 61]. The type strain is 21038. 
Figure 1.3. Neighbor-joining tree using concatenated MLSA genes showing the 
phylogenetic relationship of Lyme Borrelia group spirochetes. Black dots indicate species 
that occur in North America, circles are species that occur in Eurasia and grey don’t are 
species that occur in both old and new world [1]. 
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1.2.2.c.Borrelia bissettii 
Spirochetes now known as Borrelia bissettii were first isolated in 1987 by Bissett and 
Hill from an I. pacificus tick [67]. In 1998 after the repeated isolation of more phenotypically 
similar spirochetes, Postic et al. described the group as a novel Lyme Borrelia spirochete, B. 
bissettii [25]. The range of this group of spirochetes is quite large, and like B. burgdorferi ss 
is a Lyme Borrelia spirochete extensively described both in the New and Old World. 
Borrelia bissettii spirochetes have been detected in many states across the US, including SC, 
GA, FL, NC, MI, LA, CO, CA [58, 59, 65, 68-70]. While I. scapularis is a suspected vector, 
both I. pacificus and I. spinipalpus have been experimentally demonstrated competent 
vectors [51, 71]. Borrelia bissettii has been described in hosts, including small rodents and 
lizards [51, 65, 72].  Borrelia bissettii has been implicated by numerous studies in human 
illness, and one study has investigated B. bissettii infection and pathology in murine models 
of borreliosis [73]. Mice develop pathology within the bladder, heart and in some cases 
femorotibial joint  similar to B. burgdorferi ss. Borrelia bissettii-like spirochetes have been 
isolated from human patients in Europe, and detected by polymerase chain reaction in serum, 
blood, skin and cardiac tissue in both the US and eastern Europe [74-77]. The type strain is 
DN127. 
1.2.2.d.Borrelia burgdorferi sensu stricto 
Borrelia burgdorferi was the first Lyme Borrelia spirochete described. It was 
discovered by researchers in 1982 [18]. Initially isolated from an I. scapularis tick from 
Connecticut, the spirochete was formally described by Johnson et al. in 1984 and named after 
one of the researchers that discovered it, Dr. Willy Burgdorfer [26]. The spirochete is 
distributed worldwide and is the most commonly implicated Borrelia spirochete in human 
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Lyme borreliosis cases in the US [78]. It is a generalist spirochete and has been detected in a 
plethora of animal and tick species [15]. Its major vectors in the US are I. scapularis (Eastern 
US) and I. pacificus (Western US). Borrelia burgdorferi ss also exists in cryptic cycles. 
These cycles involve reservoir hosts and nidicoulus ticks that rarely encounter humans. 
These cycles can be extremely important as they facilitate the perpetuation of B. burgdorferi 
ss infection in wildlife [51, 79, 80]. The type strain of B. burgdorferi ss is B31. 
1.2.2.e.Borrelia carolinensis 
Between 1994 and 1997, peculiar Borrelia isolates were cultured from multiple small 
rodents (Peromyscus gossypinus and Neotoma floridana) and an I. minor tick in South 
Carolina. Sixteen of these isolates were initially classified as B. bissettii based on restriction 
fragment length polymorphism (RFLP) and pulsed field gel electrophoresis (PFGE) [57, 58, 
63, 81]. In 2009 Rudenko et al., utilizing MLST, defined these isolates as a distinct Borrelia 
species [28, 82]. Because all isolates were isolated in South Carolina, the bacteria was 
formally named Borrelia carolinensis. Borrelia carolinensis has also been detected in France 
in I. ricinus and in southern California in a cryptic cycle involving the endangered 
Armargosa vole (Microtus californicus scirpensis) and I. minor ticks [83, 84]. To date no 
experimental infection work has been completed on spirochetes from this species. Reservoir 
and vector data is solely based on survey work. Borrelia carolinensis has never been 
described in human clinical samples. The type strain is SCW-22. 
1.2.2.f.Borrelia californiensis 
Borrelia californiensis spirochetes were first isolated by Postic et al. in 1998 from a 
Dipodomys californicus [25]. In 2007, MLSA was utilized to identify the spirochete as a 
novel species [27]. Borrelia californiensis has only been detected in California in kangaroo 
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rats, mule deer and in three species of ticks (I. pacificus, Ixodes jellisonii, and I. spinipalpus) 
[25, 27, 85]. Its pathogenicity to humans is unknown, the type strain is CA446. 
1.2.2.g.Borrelia kurtenbachii 
Borrelia kurtenbachii was first isolated in 1987, in upstate New York, from an 
engorged I. scapularis larvae collected off a Peromyscus lucupus. Anderson et al. described 
it as an infectious but non-pathogenic Borrelia spirochete after testing it in an experimental 
mouse model [86]. A few years later, Fikrig et al. noted mild pathology when utilizing the 
spirochete to test a recombinant ospA vaccine [87].  A decade after its isolation, strain 25015 
was named and categorized as a Borrelia bissettii spirochete because of its similarity by 
RFLP of its 5s-23s intergenic spacer region and 16s rRNA sequences [88]. In 2010, Margos 
et al. utilized MLSA and classified strain 25015 and others like it as a new species, the 
species was named after the late Dr. Klaus Kurtenbach [2]. Studies in the mid 1990’s by Strle 
et al. and Picken et al. described isolation of spirochetes similar to strain 25015 from patients 
in Slovenia [89, 90]. Because further analysis has yet to be done on these isolates we can 
only speculate that this spirochete is a probable pathogen. The type strain is 25015. 
1.3. Mechanisms of Lyme Borrelia Infections in Vectors and Vertebrates 
Lyme Borrelia require both ticks and hosts to perpetuate in nature. Hard ticks have 
four distinct lifestages: the egg, larva, nymph and adult. After egg hatching a bloodmeal is 
required between each life stage. There is no transovarial transmission from female to egg; 
therefore, larval ticks are never infected with Lyme Borrelia [12]. Infection must be acquired 
through feeding on an infected host and to a lesser extent through co-feeding with infected 
ticks [50, 91]. Once infected, the tick will carry the infection transstadially (through molt) 
allowing competent vectors to be infected for life [92].  
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1.3.1. Tick Acquisition of Lyme Borrelia 
When an uninfected larva feeds on an infected host, acquisition of spirochetes happen 
rapidly (within 12-24 hours) and by 48 hours post tick attachment, large numbers of 
spirochetes can be visualized in the tick midgut [93]. Colonization of Borrelia in the larval 
tick is understudied; however, it is understood that certain spirochetal proteins contribute to 
the successful colonization of the larva [94]. Once in the tick’s midgut, spirochetes persist 
through bloodmeal digestion. This poses a challenge for the bacteria as the tick forms a 
temporary peritrophic membrane around its ingested meal [42]. Digestion of bloodmeal 
components is mostly intracellular, but it has been shown that byproducts of digestion may 
have an effect on the extracellular bacteria [95, 96]. After feeding is complete and bloodmeal 
digestion has occurred, the spirochetes face another harsh environment, the molt. Spirochetes 
persist to the next developmental stage in competent vectors, and during molt, yet tick gut 
epithelia cells store many macromolecules in endosomes making access to nutrients difficult 
for the extracellular spirochetes [42]. This environment also exposes spirochetes to 
temperature fluxes as seasons change. Therefore, Borrelia genomes contain many plasmid 
associated genes have been identified that facilitate colonization and persistence in the 
vector. The most studied of these include ospA, ospB and bptA [97-99]. Both ospA and ospB 
are co-transcribed on a single promotor and recombinant forms of these protein have been 
shown to bind to tick midgut [99, 100]. It has been shown that disrupting these osp genes 
does not affect acquisition but instead survival during the tick’s digestion of the bloodmeal 
[99, 100]. OspA has been shown to have a more contributory effect to this than ospB. Indeed 
a specific receptor, tick receptor for ospA (TROSPA), has been described in the I. scapularis 
midgut [101]. Borrelial persistence in ticks A (BptA) is another gene that encodes a surface 
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exposed lipoprotein which has been shown to be essential for spirochete survival through 
larval molt. Recently chemotactic genes have been identified in the B. burgdorferi ss genome 
and work is currently being conducted to determine the importance these have for tick 
acquisition [102].  
1.3.2. Tick Transmission of Lyme Borrelia 
Transmission from an infected tick to a host has been studied intensely, as this is a 
step where vaccine development has sought to exploit. With the development of in vivo 
imaging, kinetics of Borrelia dissemination in engorging ticks has been extensively teased 
apart. An infected tick has a population of spirochetes in its midgut, presumably situated in 
the ectoperiotropic space [103]. During the bloodmeal, spirochetes in an infected tick 
undergo rapid cellular division, which increases the spirochete population in the tick some 
100-fold and in turn produces a phenotypically heterogenous population [103]. This diversity 
allows a percentage of the spirochetes to penetrate the midgut epithelial wall. How this 
migration is accomplished is currently under debate. It has be suggested that active 
penetration by motile spirochetes may facilitate this process [104, 105], yet a more recent 
study suggests nonmotile spirochetes accomplish penetration via aggregated adherence to 
tick gut epithelial cells [103]. Only late into feeding do spirochetes become motile and 
traverse the hemolymphatic system. An even smaller percentage penetrates the salivary 
glands where they are subsequently transmitted to the host. This results in spirochete 
population bottlenecking and only the most fit organisms are transmitted to carry on the 
infection cycle [103].  
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Interestingly it is common that non-cultivatable spirochetes are detected in infected tick feces 
during bloodmeal digestion [106], but despite this, many spirochetes remain in the lumen, 
survive through molt, and hypothetically have the ability to be transmitted by the adult stage. 
1.3.3. Borrelia Dissemination in the Vertebrate 
Borrelia infection occurs after the bite of an infected tick. Spirochetes enter the host’s 
tissue during the blood meal and encounter components of the host’s immune system. Initial 
attachment of Lyme Borrelia to host tissue is facilitated by integrins on the spirochetes 
surface which bind to human platelets and endothelial cells [107]. To increase its chances of 
transmission from one host to another, via an arthropod, the spirochete will persist in the 
host’s blood and tissue near the site of inoculation as long as possible [108]. Spirochetes then 
begin to disseminate through local tissue matrices by a number of processes. Lyme Borrelia 
possess decorin-binding proteins that are hypothesized to promote spread through the 
collagen/decorin-rich dermal tissue [109]. Lyme spirochetes are also known to bind human 
plasminogen, which is subsequently cleaved into plasmin in the presence of urokinase-type 
plasminogen activator (uPA) [110]. It is hypothesized that this membrane-bound plasmin 
may degrade fibronectin and release/activate matrix metalloproteases (MMPs) to help the 
spirochete disseminate to tissues via a transient spirochaetaemia [111, 112].  Because 
Borrelia are a very slow replicating bacteria, immune evasion is essential for the 
dissemination and survival of the bacteria. Borrelia accomplish this feat utilizing a 
combination of tick salivary factors and a repertoire of their own immune evasion processes. 
1.3.4. Tick Saliva and Host Immunomodulation 
The bloodmeal of the hard tick can last several days [42]. Because of this, the tick 
releases components in its saliva which facilitate successful feeding [113, 114]. These 
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components include molecules that inhibit hemostasis, block pain, affect angiogenesis and 
wound healing. Most importantly for Borrelia, tick saliva contains potent immunomodulators 
of the immune system [113, 114]. Borrelia spirochetes exploit many of these components by 
utilizing tick salivary anti-complement proteins (Isac, Salp20 & TSLPI), antioxidents 
(Salp25D & ISL1373) and immune suppressing proteins (Salp15) to facilitate establishment 
in the host [6, 115-117]. These exploits are important, as immune competent hosts elicit a 
strong immune response to infection with Borrelia spirochetes [118]. Many tick-borne 
pathogens have enhanced transmission in the presence of salivary components [119]. 
Borrelia spirochetes are no exception [120]. 
1.3.5. Mechanisms of Complement Evasion 
 Complement, an innate immune system component, is one of the first hurdles 
Borrelia spirochetes encounter upon entering a host. Complement plays a critical role in 
innate defense against bacterial pathogens and utilizes over 30 serum and cellular proteins to 
promote bacterial phagocytosis and lysis via opsonization and porin formation [121]. It is an 
enzymatic process which is activated by three distinct pathways: alternative, classical, and 
lectin [121]. To combat the complement threat Borrelia spirochetes not only utilize tick 
salivary secreted anti-complement proteins, but also have a repertoire of lipoproteins 
(complement regulator acquiring surface proteins [CRASPS]) which bind components of the 
serum factor H family [122]. These proteins inhibit alternative pathways activation. Borrelia 
also recruit C4b-binding protein which inhibit the classical and lectin pathways of 
complement [123].  
Utilizing the aforementioned strategies, Borrelia are very successful in evading being 
killed by complement; however, these mechanisms have been shown to be host/Borrelia-
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species specific, as many Borrelia species differ in their ability to survive in the presence of 
different host serum [124-128]. 
1.3.6. Innate Immune Recognition of Borrelia Lipoproteins 
Initial cellular recognition of bacterial pathogens is accomplished through pattern 
recognition receptors (PRRs) like toll-like receptors (TLRs), nod-like receptors (NLRs) and 
c-type lectin receptors (CLRs). PRRs directly recognize bacterial pathogen associated 
molecular pattern (PAMPs). These receptors play an indispensable role in aspects of initial 
response to insult (innate immunity) and eventually the bacterial specific adaptive response 
of the immune system.  Recognition of B. burgdorferi ss lipoproteins through TLR2 [129], 
NOD2 [130] and TLR8 when internalized in phagolysosomes [131] all play a critical role in 
recognition spirochetes and  promotion of downstream immune system modulators such as 
pro-inflammatory molecules, cytokines and chemokines. 
1.3.7. Lyme Borrelia and Phagocytes 
Phagocytes also play a role in host defense against Borrelia infection. Monocyctes, 
macrophages, neutrophils and glial cells have all been identified as potent phagocytes of B. 
burgdorferi in vitro [132, 133]. Borrelia spirochetes are very motile and are able to escape 
phagocytosis, yet when unable, phagosomal digestion of the bacteria is a potent signal for 
downstream inflammatory cytokines [131]. 
1.3.8. Lyme Borrelia Interactions with T-cells, B-cells and Antibodies   
T-cell involvement in Lyme borreliosis is still a young area of study. Mouse studies 
have demonstrated that CD4+ T cells play a role in controlling spirochatemia, while CD8+ T 
cells seem to promote disease process. Development of a specific anti-Borrelia humoral 
response is critical to clearing the pathogen [134]. Early production of IgM by B-Cells helps 
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control initial spirochete burdens [135] while B-cell antibody class-switching and production 
of specific IgG is quickly initiated and can be detected two weeks post infection. To counter 
antibody mediated killing Borrelia spirochetes have been demonstrated to employ an 
antigenic variation system, which begins with the initial down regulation of the major surface 
lipoprotein ospC and then the activation of the vlsE locus, which uses a repertoire of 
transposable antigenic cassettes to change its surface lipoprotein coat aiding in evasion of the 
host immune response [136-138].  
1.4. Lyme Disease (Borreliosis) 
Lyme borreliosis most likely plagued humans before it was discovered in the late 20th 
century. Historical records describe diseases such as “Montauk knee” afflicting people in 
New York and tick associated skin rashes in Europe. Borrelia burgdorferi has also been 
identified in a 5,300 year old ice man discovered in the Eastern Alps [139-141]. Recently, 
Borrelia spirochetes predating humans have also been identified in a 15 million year old 
amber-fossilized Amblyomma spp. tick discovered in South America [16]. However, clinical 
Lyme borreliosis was first described in the United States in 1977 by Steere et al., only after a 
concerned citizen recognized the large number of children afflicted by what was supposed to 
be a rare disease, Juvenile Rheumatoid Arthritis [142]. Dr. Alan Steere was a medical doctor 
studying arthritis at Yale medical school when he was contacted to look into the peculiar 
occurrence. Ticks from the area were coincidently being sent to Rocky Mountain Labs where 
Dr. Willy Burgdorfer was examining them for the presence of Rickettsia. It was there that Dr. 
Burgdorfer noticed spirochete bacteria in the tick’s midgut. Five years later, B. burgdorferi, 
the causative agent of Lyme borreliosis was formally described [18]. 
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1.4.1. Epidemiology of Lyme Borreliosis in the United States 
 Since the discovery of Lyme, the incidence of human disease has steadily increased 
(Figure 1.4) [78, 143]. Currently the Centers for Disease Control (CDC) estimates almost 
300,000 cases of Lyme are diagnosed every year [144, 145]. The majority of Lyme disease is 
reported from two regions of the US, mainly the Great Lake states and the Northeast (Figure 
1.5). For example in 2012, 95% of the total human Lyme cases were reported from 13 states 
(Table 1.2). Lyme borreliosis has a bimodal age distribution peaking in children age 5-10 and 
adults 40-55 years old (Figure 1.6). Lyme affects both genders equally (53% in males) but 
does overwhelmingly affect Caucasians (94% of all reported cases) [78]. Disease is more 
common when vector ticks are active: June-August (Figure 1.7). The risk of contracting the 
disease increases with the amount of time spent outdoors in or near wooded areas [146].  
1.4.1.a.Southern Lyme Borreliosis 
Occurrence of human Lyme borreliosis outside of the traditional hyperendemic zones 
(Northeast and Great Lakes) is a topic of great debate. This is especially true in areas where 
the vector tick occurs in abundance yet human cases of Lyme occur infrequently. Areas like 
the southern US have traditionally supported large populations of I. scapularis [147] yet, as 
seen in Table 1.2, report relatively few cases of human Lyme yearly. Hypotheses attempting 
to explain this phenomenon have existed for decades; however, the scientific community has 
yet to pinpoint the exact mechanism. One observation widely accepted is that the I. 
scapularis nymph is responsible for transmitting the majority of Lyme Borrelia to humans. 
This is supported in part by the seasonal overlap of disease occurrence and phenology of the 
nymphal ticks in hyperendemic regions [148]. 
Table 1.2. Number of reported Lyme disease cases in 2012 reported to the CDC by State. 
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Figure 1.5. Lyme disease cases reported in the US in 2012. 
One dot placed randomly within the county of residence for 
each confirmed case of human Lyme borreliosis. 
http://www.cdc.gov/lyme/stats/maps/map2012.html 
Figure 1.4. Number of human Lyme disease cases reported to the 
CDC yearly from 2003-2012. *Case definition was changed in 
2008 to delineate probable cases from confirmed cases. 
http://www.cdc.gov/lyme/stats/chartstables/casesbyyear.html 
Figure 1.6. Cases of Lyme disease reported to the CDC from 
2001-2010 defined by age and gender. 
http://www.cdc.gov/lyme/stats/chartstables/incidencebyages
ex.html 
Figure 1.7. Month of disease onset as reported to the 
CDC in cases of Lyme disease from 2001-2010. 
http://www.cdc.gov/lyme/stats/chartstables/casesbymo
nth.html 
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Because of their small size, nymphs are also more likely to go undetected during attachment. 
In hyperendemic areas, nymphal ticks can be found in abundance, but this is not true in areas 
like the southern states (SC, GA, MS, LA, FL) where it is rare to encounter a nymphal I. 
scapularis [149]. This is peculiar because of the abundance of adult I. scapularis (Figure 1.8) 
[44].  
State # of cases 
Top 13 
Connecticut 2657 
Delaware 669 
Maine 1111 
Maryland 1651 
Massachusetts 5138 
Minnesota 1515 
New Hampshire 1450 
New Jersey 3616 
New York 2998 
Pennsylvania 5033 
Vermont 522 
Virginia 1110 
Wisconsin 1766 
Southern States 
Alabama 25 
Arkansas 13 
Florida 118 
Georgia 31 
Louisiana 7 
Mississippi 1 
North Carolina 122 
South Carolina 44 
Texas 25 
*Data represents both confirmed and probable cases reported at 
http://www.cdc.gov/lyme/stats/chartstables/reportedcases_statelocality.html 
Table 1.2. Number of reported Lyme disease cases in 2012 reported to the CDC by State. 
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One of the first explanations of this phenomenon was that there existed two distinct species 
of ticks: one (Ixodes dammini) populated areas North of Maryland and another (I. scapularis) 
South of MD. Ixodes dammini was described as a novel species in 1979 based on 
morphological differences noted between southern and northern I. scapularis ticks [150]. The 
delineation of these two species would help explain the human borreliosis incidence 
differences by: 1) questioning vector competence of the southern I. scapularis [151] and 2) 
explaining observed nymphal human biting differences between the two species [152, 153]. 
Eventually; however, the conspecificity of the two species of ticks was proven by genetic, 
morphological and cross -breeding experiments [44, 154, 155]. While southern I. scapularis 
were confirmed competent vectors of B. burgdorferi ss [156-158], to date, the reduced 
human exposure to southern nymphal I. scapularis has yet to be elucidated. Large ecological 
studies in the southern US consistently show that populations of I. scapularis are infected 
with B. burgdorferi ss at low levels [159-163]. These findings have widely been attributed to 
the different feeding behavior exhibited by I. scapularis in southern states, where the 
Figure 1.8. Known distribution of Ixodes scapularis in the United States. 
http://www.cdc.gov/ticks/geographic_distribution.html#blacklegged. 
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majority of data suggest that the immature life stages feed on Borrelia-refractory lizards 
[164, 165]. Reduction of the number of immature vectors on highly competent Borrelia 
reservoirs (Peromyscus spp.) directly decreases the prevalence of Borrelia in the ticks [166].  
However, some evidence exists that at least some lizards are susceptible to Borrelia infection 
[167-169]. Experimental studies have not shown a distinct preference for feeding on lizards 
[170]; therefore, it is postulated that a general increase in host biodiversity has a negative 
correlation (dilution effect) on Borrelia infection in vector ticks [171]. Still, the dilution 
hypothesis has come under attack [166, 172]. Only will further research in these understudied 
areas really shine a light on what is actually occurring. 
1.4.2. Human Lyme Borreliosis 
Lyme Borreliosis is generally broken down into three stages: stage one being early 
infection, stage two termed early disseminated, and stage three referred to as late disease 
[173]. Stages one and two are considered the early phase of the disease and occur a few 
weeks to a couple months post infection and present with self-limiting signs and symptoms. 
Chronic or late disease occurs years after infection and can become progressive [173].  
1.4.2.a.Early Borrelia Infection (Stage 1) 
Initial infection (stage 1) causes a localized rash know as a bulls-eye rash or erythema 
migrans (EM) and limited systemic signs (fever, headache, malaise, and muscle aches) [174]. 
The EM rash (considered pathognomonic in endemic areas) grossly appears as a red, 
centrally-expanding rash with a diameter from 5 cm to sometimes > 20cm in diameter. This 
occurs one to four weeks after a tick bite (Figure 1.9 A&B) [174].  
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There exists no catch-all definition for the EM rash as they can present in many forms 
including ovid, circular, triangular, and generally lacking regular borders and may or may not 
show central clearing [175-177]. 
1.4.2.b.Early Disseminated Borrelia Infection (Stage 2) 
Stage 2 or early disseminated disease is characterized by haemateogenous 
dissemination of the Lyme spirochete in an untreated host. This occurs within the first month 
post infection [173]. Clinical signs during this stage of infection include neurological 
manifestations (Lyme neurroborreliosis, LNB) and cardiac involvement (Lyme carditis), in 
15% and 8% of individuals, respectively [178, 179]. The most common neurological sign in 
the United States is subacute meningitis, which can have associated transient facial paralysis 
(bell’s palsy) (Figure 1.9 C) and peripheral neuropathy [180]. Signs and symptoms of these 
manifestations include fever, neck pain/tenderness, facial paralysis (unilateral or bilateral), 
and numbness or tingling in the extremities [180].  Neurological involvement is a result of 
haemateogenous dissemination of the spirochete into the leptomeninges, nerve roots, dorsal 
root ganglia, and cerebral spinal fluid (CSF) of the host [179, 180].  
Figure 1.9. Clinical manifestations of Lyme borreliosis. A; Erythema migrans lacking 
central clearing, B; EM with central clearing and tick punctum, C; Bell’s palsy, D; Lyme 
Arthritis. 
 27 
 
Lyme carditis is another manifestation in the early disseminated phase of Lyme 
borreliosis. While neurological involvement is more common, cardiac signs and symptoms 
are implicated in patient morbidity and in some cases mortality [181, 182]. Borrelia 
spirochetes disseminate to the heart via blood vessels and can infect all layers of the 
myocardium [181, 183]. Lyme carditis can present as a magnitude of signs and symptoms, 
ranging from non-specific (light-headedness, syncope) to palpitations and even myocardial 
infarction [181]. However, the most common reported sign are cardiac conduction delays, 
most commonly atrioventricular blocks (2° Type 1 & 3°) [181]. Both cardiac and 
neurological manifestations are directly related to the presence of the bacteria, and upon 
bacterial clearance symptoms alleviate [179, 181].  
1.4.2.c.Late Borrelia Infection (Stage 3) 
The final stage of Lyme disease is termed late disease. This occurs months to years 
post infection in untreated individuals. In the US, Lyme arthritis is the most common 
manifestation at this point of the disease’s pathogenesis, but can occur at any stage in the 
disease [173]. Unlike rapid arthritis seen in normal bacterial septicemia, the Lyme spirochete 
does not produce proteases, and degeneration of joints are due to monocyte/macrophage, 
immune complex and complement infiltration into the synovial fluid [184]. Lyme arthritis 
presents almost exactly like other chronic inflammatory arthritides with arthralgia 
intermittently affecting large weight bearing joints such as the knees (Figure 1.9 D) [173, 
185]. 
1.4.2.d.Post Treatment Lyme Disease Syndrome (PTLDS) and “Chronic” Lyme Disease 
Finally there exists two additional termed stages of Lyme disease, sometimes used 
interchangeably, that are not well understood and even controversial. The first is a condition 
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known as Post Treatment Lyme Disease Syndrome (PTLDS). This condition was first termed 
in the late 1990s but has recently gained more attention in the scientific community [186]. 
The syndrome itself occurs in around 10-20% of patients and it is marked by lingering 
symptoms, after the recommended antibiotic treatment regime, including but not limited to 
fatigue, pain, and joint or muscle aches [187-190]. The cause of PTLDS has not been 
determined and studies have posited many different explanations [191-194]. 
The second additional stage is loosely termed chronic Lyme disease. This stage, like 
PTLDS manifests months to years after antibiotic treatment. It is hypothesized that in chronic 
Lyme cases, antibiotic treatment is unable to “kill” all the spirochetes, possibly due to their 
dissemination to immune privileged sites such as the CNS and cartilaginous tissues [195]. 
While some animal studies support this notion [196-198] the debate continues.   
1.4.3. Murine Model of Lyme Borreliosis 
Like many diseases, the laboratory mouse model plays an important role in many 
aspects of Lyme Borrelia research. Mice (Mus musculus) have been shown to be susceptible 
to many species of Borrelia infection, yet different strains display a wide range of symptoms 
[6, 199, 200]. The murine model of Lyme borreliosis offers several advantages in the study 
of this disease process. 1) Murine models, being so common, are economical; they are also 
genetically and microbiologically defined. 2) Mice are susceptible to multiple species of 
Borrelia at all ages. 3) Many mice consistently develop both heart and joint disease during 
the course of infection. 4) Many of the disease manifestations seen in mice also parallel 
features of human infection. 5) Mice also develop a serological response, which can be 
helpful when developing and testing diagnostic tests. 6) Mice are also competent host for 
many of the tick species that serve as ecological vectors for Lyme Borrelia, which allow for 
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the study of the vector-host-pathogen interface, the triad of vector-borne disease research 
[201]. The availability of murine microbiological reagents, complete murine genome and 
availability of hundreds of transgenic and knockout mice allow for economical and 
expeditious experimentation. To date, mice have been shown to be susceptible to at least 
seven B. burgdorferi sl species of spirochetes [73, 86, 202-206]. And while some gross 
pathological signs, like arthritis, differ between strains of mice (C57BL/6 and BALB/c show 
less joint swelling then do C3H mice), disseminated infections are common in many models 
[201]. Severe combined immunodeficient (scid) mice are also commonly utilized in Lyme 
Borrelia research as they lack an adaptive immune response and are very susceptible to 
microbes, therefore, they are often utilized to test infectivity of even the weakest Borrelia 
species and mutants [201]. In comprehensive studies of B. burgdorferi ss infection done by 
Barthold et al. [201, 207, 208] dissemination of spirochetes was monitored as were clinical 
manifestations. Dissemination of spirochetes to blood and spleen is seen by day 3 post 
inoculation. By day 10, spirochetes colonize the ear tissues and invasion of joints occurs day 
4 through 7 followed by heart colonization at days 7 through 10. Spirochete burdens peak at 
day 15 but persist for at least a year. Spirochetes showed a predilection for collagenous, 
heart, joint, arteries, nerves, muscles, skin and other tissues. Musculoskeletal pathology 
manifests as arthritis most often in the tibiotarsal joint. This is most likely due to edema 
secondary to infiltration of neutrophils and macrophages in response to large numbers of 
bacteria. Cardiovascular pathology occur at the aortic root, auricles and ventricular 
myocardium. With the exception of aortitis, due to neutrophilic infiltration, the major cause 
of pathology in the cardiac tissues is secondary to macrophage infiltration. Spirochetes can 
be visualized throughout the heart early, yet are mostly cleared by the immune system except 
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that some persist in the aortic wall at the base of the heart. The bladder can also exhibit 
lesions secondary to spirochete infection [201, 207, 208]. Mice develop a robust antibody 
response to many of the immunogenic proteins that the human immune system also 
recognizes [208]. This is of great use in testing and developing both serological diagnostic 
test and vaccine candidates. Lastly, mice serve as competent host for both immature stages of 
the human vectors for Lyme Borrelia and are susceptible to infection via tick bite [209, 210].  
The murine model of Lyme borreliosis offers many benefits to researchers, however 
does come with limitations. Mice are not genetically similar to humans and to date, only non-
human primates (NHP) have been shown to reliably mimic many of the human symptoms of 
Lyme infection (erythema migrans, arthritis, carditis and neurological manifestations) [211-
215]. While the NHP models incur high costs, special facilities, and specific training they 
remain the closest model to human Lyme borreliosis described to date. Future work should 
utilized the invaluable NHP models to clarify human clinical sign and symptoms of the lesser 
studied Lyme Borrelia. 
1.4.4. Diagnosis of Lyme Borreliosis  
Considering Lyme disease is estimated to cause ~300,000 cases of human illness a 
year in the US, the research focused to Lyme Borreliosis diagnosis has been very substantial 
[145]. Diagnosis of Lyme disease in the United States is based on a combination of criteria 
that include the identification of clinical signs and symptoms, tick exposure history, and 
laboratory diagnostic tests [216]. However, many of the signs and symptoms of Lyme 
disease can vary between species and even strains of Lyme Borrelia infecting the individual 
[217, 218]. Therefore, both defining areas of endemic tick infection and laboratory diagnostic 
assays are a critical tool in the diagnosis of human Lyme borreliosis.  
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1.4.4.a.Two-Tier Serological Testing 
Currently the Infectious Disease Society of America (IDSA) and the CDC 
recommend a two-tiered approach for clinical laboratory diagnosis. The first tier is a whole-
cell IgM and IgG enzyme-linked immunosorbent assay (ELISA). If the ELISA is positive or 
equivocal it is followed by the second tier which is a western blot [219, 220]. Because the 
whole-cell ELISA has high sensitivity but lower specificity, a western blot is performed to 
confirm a positive or equivocal ELISA [216]. Criteria for a positive western blot are defined 
by the IDSA and CDC as 
“an IgM immunoblot be considered positive if two of the following three 
bands are present: 24 kDa (ospC), 39 kDa (bmpA), and 41 kDa (fla). An IgG 
immunoblot be considered positive if five of the following 10 bands are 
present: 18 kDa, 21 kDa (ospC), 28 kDa, 30 kDa, 39 kDa (bmpA), 41 kDa 
(fla), 45 kDa, 58 kDa (not groEL), 66 kDa, and 93 kDa. [219, 220]”  
These recommended two-tiered diagnostic tests are based on proteins derived from 
the organism B. burgdorferi ss. While it has been demonstrated that this approach is adequate 
to diagnose infection with B. burgdorferi ss and a few strains of other Lyme Borrelia [216, 
221, 222], problems arise when infection is caused by other know human pathogenic Lyme 
Borrelia. These problems can materialize as weak banding patterns or less than two (IgM) or 
five (IgG) bands present [221, 223-227].  
Eurasia experienced problems with Lyme borreliosis diagnosis shortly after the initial 
description of the disease. The first serological tests were developed based on immunogenic 
proteins from North American B. burgdorferi ss organisms. Patients in Eurasia were 
presenting with different clinical manifestations than those in the US [228, 229]. Spirochetes 
isolated from patients and vector ticks were also phenotypically different from North 
American Borrelia species [229]. Eventually, multiple species of Borrelia, notably Borrelia 
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afzellii and Borrelia garinii, were confirmed as additional pathogenic spirochetes [19]. 
Serological test initially developed for B. burgdorferi ss were found to be less effective in the 
detection of these Eurasian pathogenic Borrelia [230, 231]. Subsequently, researchers and 
clinicians in these areas realized that to increase specificity and sensitivity of the diagnostic 
tests it would be to their advantage to use multiple species and local isolates of B. 
burgdorferi sl spirochetes [226, 232].  
1.4.4.b.C6 Peptide ELISA 
Another serological test that has been extensively compared with the standard two-
tier testing methods is the C6 Peptide ELISA. The test is based on a 26-mer amino acid 
peptide developed against an invariant region (IR6) of the well-studied virulence associated 
outer surface vlsE protein [233]. This protein is largely responsible for antigenic variation 
during vertebrate infection [136]. This peptide is based on the B. burgdorferi ss vlsE protein 
sequence but has been shown to be conserved among the three major pathogenic Borrelia 
spp. (B. burgdorferi ss, B. afzelii and B. garinii) [234]. Multiple studies have concluded the 
C6 peptide ELISA is comparable if not more reliable than the current two-tier testing 
approach for Lyme borreliosis diagnosis [235-237]. 
Diagnosis of Lyme borreliosis is an evolving field. Borrelia burgdorferi sl infections 
can cause a wide variety of clinical signs [238, 239], overlap geographically [1, 240], and 
have differential reactivity to a variety of serological diagnostic tests [230, 231]; therefore, it 
is essential that we understand the infectivity and host response to all Borrelia species 
endemic to certain areas, as Borrelia infections could easily be overlooked.  
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1.5. Summary 
Lyme borreliosis is a recently emergent vector-borne disease. Advancements in 
science have allowed researchers to elucidate minute details involving this organism and its 
disease. However, there remains much research to be done. An estimated 300,000 cases of 
Lyme disease are diagnosed each year in the United States and the zones of endemicity keep 
expanding. Much research has been focused on the B. burgdorferi ss species and its vector in 
areas of high endemicity. This most certainly was warranted; however, important aspects of 
the larger Lyme borreliosis picture were overlooked, as demonstrated with the clinical and 
diagnostic issues once faced in Eurasia. One can argue that we are seeing the same issue here 
in the US. It may have started with the I. dammini/I. scapularis debate but it continues with 
the “recent” spread of Lyme into non-traditional endemic areas (Virginia, Michigan and 
Canada). While descriptions of new Lyme Borrelia species seem to be published weekly, 
there continues to be a lacks of fundamental understandings into their infectivity, ecology 
and general biology. In this dissertation we take a broad approach to provide evidence that 
may explain, at least in part, some of these issues. We hypothesize that the Lyme borreliosis 
picture in the US is much more complex then we currently understand this is in part due to 
undescribed populations of Lyme Borrelia in states outside of hyperendemic areas and the 
presence of one or more additional pathogenic Lyme spirochetes in the US. 
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CHAPTER 2. DETECTION OF HUMAN BACTERIAL PATHOGENS IN TICKS 
COLLECTED FROM LOUISIANA BLACK BEARS (URSUS AMERICANUS LUTEOLUS) 
 
2.1. Abstract 
There are four major human biting ticks in the noutheastern United States, which 
include: Amblyomma americanum, Amblyomma maculatum, Dermacentor variabilis, and 
Ixodes scapularis. The black bear is a large mammal that has been shown to be parasitized by 
all the aforementioned ticks. We investigated the bacterial infections in ticks collected from 
Louisiana black bears (Ursus americanus subspecies luteolus). Eighty-six ticks were 
collected from 17 black bears in Louisiana from June 2010 to March 2011.  All four common 
human biting ticks were represented. Each tick was subjected to polymerase chain reaction 
(PCR) targeting select bacterial pathogens and symbionts. Bacterial DNA was detected in 
62% of ticks (n=53). Rickettsia parkeri, the causative agent of an emerging spotted fever 
group rickettsiosis, was identified in 66% of A. maculatum, 28% of D. variabilis and 11% of 
I. scapularis. The Lyme disease bacterium, Borrelia burgdorferi, was detected in two I. 
scapularis, while one A. americanum was positive for Borrelia bissettii, a putative human 
pathogen. The rickettsial endosymbionts Candidatus Rickettsia andeanae, rickettsial 
endosymbiont of I. scapularis and Rickettsia amblyommii were detected in their common tick 
hosts at 21%, 39% and 60%, respectively. All ticks were PCR-negative for Anaplasma 
phagocytophilum, Ehrlichia spp. and Babesia microti. This is the first reported detection of 
R. parkeri in vector ticks in Louisiana; we also report the novel association of R. parkeri with 
I. scapularis.  
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Detection of both R. parkeri and B. burgdorferi in their respective vectors in Louisiana 
demands further investigation to determine potential for human exposure to these pathogens.    
2.2. Introduction 
Since Theobald Smith’s seminal work describing ticks as the vectors for Texas cattle 
fever, the importance of arthropods as vectors for disease has surged to the forefront of both 
human and animal medicine [1]. By the turn of the 20th century many control measures were 
developed and deployed to combat the pests spreading these pathogens. Excellent reviews of 
these can be found in Hill et al. (2005) and Piesman & Eisen (2008). Even with advances in 
arthropod control and disease management the world has seen an emergence and re-
emergence of zoonotic vector-borne diseases (ZVBD) within the past 30 years [2, 3].  
Ticks are vectors for a plethora of zoonoses, which include the causative agents of 
anaplasmosis, babesiosis, erhlichiosis, Lyme and relapsing fever borreliosis, spotted fever 
group (SFG) rickettsiosis and a host of viral diseases [4, 5]. In the United States, ticks 
transmit more vector-borne diseases than any other arthropod. With over 80 known species 
of ticks in the US, opportunity exists for each one of the aforementioned diseases to affect 
humans and animals [6].  
Not only is the US witnessing a steady increase in reported human cases of many 
tick-borne diseases, new tick borne pathogens are being discovered on a regular basis. For 
example in 1992, Lyme disease, Rocky mountain spotted fever (RMSF) and tularemia were 
the only nationally notifiable tick-borne diseases; approximately 20 years later the number 
has swelled to nine [7]. This increase amounts to three new tick-borne human diseases 
identified per decade. With the advent of better detection, diagnosis and surveillance, this 
number is likely to increase.  
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Despite the increase in research on tick and tick-borne diseases conducted elsewhere 
in the past several decades, comparatively less work has been done in Louisiana. With 
outdoor activity as the single most important risk factor for tick exposure [8], and  
Louisiana’s recognition as “A Sportsman’s Paradise,” there is strong risk of tick exposure for 
both residents and visitors. In the southern US humans are most commonly parasitized by 
four ticks species: Amblyomma americanum, Amblyomma maculatum, Dermacentor 
variabilis and Ixodes scapularis [9-11]. Each of these tick species have unique host 
preferences that, taken together, encompasses a range of host animals [12]. Black bears have 
been reported to harbor many of the same tick species as humans, and not surprisingly, 
pathogenic bacteria have been detected in ticks parasitizing bears [13-19]. 
Louisiana’s state animal is the black bear, Ursus americanus subspecies luteolus, 
which has been listed as a threatened species by the United States Fish and Wildlife Service 
since 1992. The Louisiana department of Wildlife and Fisheries carefully monitors bear 
populations throughout the state and has collected ectoparasites during these monitoring 
efforts. The objective of our study was to investigate which ticks parasitize black bears in 
Louisiana, and to identify bacteria of interest that they harbor. 
2.3. Materials and Methods 
2.3.1. Bear Sampling and Tick Collection  
From June 2010 to March 2011 ticks were collected from 17 black bears throughout 
Louisiana by personnel from Louisiana’s Department of Wildlife and Fisheries (LDWF). 
Ticks collected off bears in this study were convenience samples, as the bears consisted of 
relocated and accidentally or illegally killed animals encountered by LDWF personnel. Bears 
were sampled from seven parishes: Concordia, Iberville, Livingston, Madison, Pointe 
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Coupee, St. Landry and St. Mary. Exhaustive searching of bears for ectoparasites was not 
conducted, leading to the collection of only easily visible adult ticks. Ticks were stored in 
70% ethanol for transport, then identified and sexed using standard identification keys [20, 
21].  
2.3.2. Tick DNA Extraction  
Ticks were surface sterilized by first soaking in a 10% bleach solution, followed by a 
phosphate buffered saline (PBS) wash, next soaked in a 70% ethanol solution, followed by a 
PBS wash and finally a soak in molecular biology grade water (MO BIO, Carlsbad, CA). 
Individual ticks were then bisected with a sterile scalpel and DNA was extracted from each 
tick using the GenElute DNA extraction Kit (Sigma, St. Louis, MO) following 
manufacturer’s instructions with minor modifications. These modifications included: tick 
tissues were allowed to lyse overnight in a 55˚C water-bath and DNA was eluted in 100 µl of 
supplied elution buffer. DNA was stored at -20˚C until PCR was performed. 
2.3.3. Polymerase Chain Reaction 
Polymerase chain reaction (PCR) was performed on DNA extracts to detect the 
presence of selected bacteria. The PCR assays targeted the following genes: msp2 for 
Anaplasma phagocytophilum [22], 18s rRNA for Babesia microti [23], flaB for Borrelia 
burgdorferi sensu lato [24], 16s rRNA for Ehrlichia species [25, 26] and both 17-kDa antigen 
gene [27] and ompA [28] for SFG Rickettsia. Environmental controls were utilized for 
detection of DNA artifact contamination in all experiments this included: simultaneous 
extraction tubes with no tissue added for all DNA extractions and molecular biology grade 
water (MO BIO) used as a template in the downstream PCRs. Initial reactions contained 2.5 
µL of DNA extract in a total reaction volume of 25 µL. TaKaRa Taq DNA polymerase 
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(TaKaRa-Bio Inc, Otsu, Japan) was utilized in all reactions. Each reaction had a final 
concentration of 1.25 U of Taq DNA polymerase, 45 mM KCL, 2.5 mM MgCl2 , 200 M 
concentration of each deoxynucleoside, and 0.5 M of the upstream and downstream 
primers. All reactions were carried out in a My Cycler thermal cycler (BioRad, Hercules, 
CA.) Nested reactions contained 1 µL of product from outer reaction under the same master 
mix concentrations. Thermocycling protocols were followed as published for each primer set. 
2.3.4. DNA Purification/Sequencing/Analysis 
PCR products were electrophoresed on a 2% agarose gel and stained with ethidium 
bromide. Bands of the correct size were purified with a QIAquick PCR purification kit 
(Qiagen, St. Louis, MO) and bi-directionally sequenced on an automated ABI 3130 Genetic 
Analyzer (Applied Biosystems, Foster City, CA.)  at LSU’s Biommed Gene Lab. Sequences 
were aligned using ClustalX and compared with existing sequences in the National Center 
for Biotechnology Information (NCBI) GenBank using the Basic Local Alignment Search 
Tool (BLAST) [29, 30].   
2.3.5. PCR Cloning  
PCR-cloning was utilized to identify amplicon inserts in samples where multiple 
signals were detected in the sequencing chromatograph. Cloning reactions were performed 
according to manufacturer’s instructions with an Invitrogen Topo TA cloning kit (Life 
Technologies, Grand Island, NY). Multiple colonies were picked and the universal primers 
M13F and M13R were used to sequence as previously described. The resulting sequences 
were aligned and analyzed as described above. 
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2.4. Results 
2.4.1. Four Tick Species were Found Parasitizing Louisiana Black Bears 
Eighty-six ticks were removed from a total of 17 bears. All ticks collected were 
adults; 51% (n=44) were females and 49% (n=42) were male. A. maculatum was the most 
commonly collected tick, comprising 44% of all ticks collected (n=38), D. variabilis 
represented 29% (n=18) of the total collected, I. scapularis was the next most abundant at 
21% (n=15) and the least common was A. americanum at 6% (n=5) (Table 2.1).  
Bear A. americanum A. maculatum D. variabilis I. scapularis Total  
1 - 4 (M), 4 (F) 1 (M) - 9 
2 - 2 (M), 4 (F) 1 (F) - 7 
3 - - 2 (M), 1 (F) - 3 
4 - 9 (M) 2 (M), 3 (F) - 14 
5 - - 1 (M), 6 (F) - 7 
6 - 3 (M), 1 (F) 1 (M), 3 (F) - 8 
7 - - 1 (F) - 1 
8 - - 1 (F) - 1 
9 - 1 (M) 1 (M), 1 (F) - 3 
10 - 9 (M), 1 (F) - - 10 
11 - - - 2 (M), 3 (F) 5 
12 - - - 2 (M), 1 (F) 3 
13 - - - 2 (F) 2 
14 - - - 2 (F) 2 
15 - - - 2 (F) 2 
16 3 (M), 2 (F) - - - 5 
17 - - - 2 (M), 2 (F) 4 
Total 5 38 25 18 86 
 
 
Table 2.1. Number, species and gender of ticks (M=male, F=female) collected 
from each of the bears in this study 
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2.4.2. Three Bacterial Pathogens were Detected in Ticks 
DNA was extracted from all 86 ticks collected from Louisiana black bears. These 
extracts were tested for the presence of A. phagocytophilum, B. burgdorferi sensu lato, B. 
microti, Ehrlichia spp. and SFG Rickettia DNA by PCR. Pathogenic bacterial DNA was 
detected in 44% (n=38) of all ticks. Rickettsia parkeri was detected most frequently with 25 
of 38 (65.7%) A. maculatum, 7 of 25 (28%) D. variabilis and 3 of 18 (11.1%) I. scapularis 
testing positive. Rickettsia parkeri sequences were 99% homologous with sequences in 
GenBank (Table 2.2). Evidence of B. burgdorferi sensu stricto was found in 2 of 18 (11%) I. 
scapularis, while one (20%) A. americanum had a sequence matching Borrelia bissettii 
(Table 2.2).  No A. phagocytophilum, B. microti or Ehrlichia species DNA were detected in 
any of the ticks.  
2.4.3. Three Rickettsial Endosymbionts were Detected in Ticks  
Spotted fever group Rickettsia primers and subsequent sequencing identified 
rickettsial endosymbiont DNA in 20.9% (n=18) of their respective ticks. These 
endosymbionts included: Candidatus Rickettsia andeanae in 8 of 38 (21%) A. maculatum, 
rickettsial endosymbiont of I. scapularis in 7 of 18 (38.8%) I. scapularis, and Rickettsia 
amblyommii in 3 of 5 (60%) A. americanum. Endosymbionts were 99-100% similar to their 
respective reference sequences in Genbank (Table 2.2).   
2.4.4. Multiple Bacteria Detected in Ticks 
Ticks with evidence of mixed SFG Rickettsia DNA after sequencing were subjected 
to PCR cloning and sequencing of multiple clones to identify individual amplicons. Two 
ticks had the presence of multiple SFG Rickettsia DNA. This included one A. maculatum 
with both Candidatus R. andeanae and R. parkeri, and one I. scapularis with the rickettsial 
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endosymbiont of I. scapularis and R. parkeri. Two additional ticks had evidence of multiple 
bacteria by separate PCRs. In one I. scapularis, we detected both B. burgdorferi and the 
rickettsial endosymbiont of I. scapularis and one A. americanum had evidence of both R. 
amblyommii and B. bissettii DNA (Table 2.2).  
2.5. Discussion 
In this study we investigated which species of ticks were parasitizing Louisiana black 
bears and identified both pathogenic and symbiotic bacterial DNA in the arthropods.  
Human-biting ticks have been commonly recorded on bears in studies across the US dating 
back to the mid 70’s [13, 14, 18, 19, 31]. A previous study in Idaho detected antibodies to 
multiple tick borne pathogens in black bears while a Wisconsin study isolated Lyme Borrelia 
spirochetes from these animals [15, 17];  more recently Yabsley et al. (2009) detected 
Ehrlichia chaffeensis and R. parkeri in ticks from black bears in South Georgia/ North 
Florida. Consistent with these previous reports, black bears in Louisiana harbor many 
common human-biting ticks; nearly half of these had PCR evidence of bacterial pathogens.  
Most importantly this is the first record of R. parkeri infection occurring in its natural vector 
in Louisiana, with almost 66% of the A. maculatum we tested having evidence of R. parkeri. 
This coincides with a recent publication detecting R. parkeri in the blood of dogs in 
Louisiana [32].  Rickettsia parkeri rickettsiosis is an emerging infectious disease. Detection 
of R. parkeri is becoming more common across the range of its primary vector, A. 
maculatum. Published infection rates of R. parkeri range from ~10-40% in populations of 
southeastern A. maculatum ticks [33-37]. Multiple ticks from multiple parishes in Louisiana 
had evidence of R. parkeri infection (Figure 2.1). Rickettsia parkeri was also detected in both 
D. variabilis and I. scapularis. This is the first record of detection of this SFG Rickettsia in I. 
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scapularis ticks. These ticks are not considered vectors for R. parkeri but are known to 
harbor other SFG Rickettsia. Interestingly,  we detected R. parkeri in two male I. scapularis, 
considering male Ixodes ticks feed sparingly if at all, this finding raises the question of 
pathogenic SFG Ricksttia infection in I. scapularis [38]. Identifying such a large number of 
R. parkeri infected ticks associated with bears also proposes the question of the bear as a 
potential reservoir host. Lyme Borrelia spirochetes were detected in three ticks. B. 
burgdorferi sensu stricto was detected in two I. scapularis while B. bissettii was detected in a 
male A. americanum. Borrelia burgdorferi sensu stricto is the leading cause of the most 
common vector-borne disease in the US, Lyme borreliosis. Borrelia bissettii is a closely 
related Lyme spirochete that shares common vectors, hosts and geographic range, and more 
recently has been implicated in human disease [39-41]. Many species of ticks are associated 
with distinct endosymbiotic bacteria [46]. In this study we detected multiple symbiotic SFG 
Rickettsia. Candidatus R. andeanae is a recently isolated SFG Rickettsia and a putative 
endosymbiont of A. maculatum ticks [47]. It has been reported in multiple regions of the US 
where A. maculatum are found [34, 35, 48]. Our finding of Candidatus R. andeanae in 21% 
of A. maculatum is the first evidence of this bacterium in Louisiana and expands the known 
range of this recently described SFG Rickettsia. Detection of other SFG rickettsial 
endosymbionts, namely R. amblyommii in A. americanum and the rickettsial endosymbiont 
of I. sapularis, is not unexpected, and, these are the first published records of these SFG 
Rickettsiae in Louisiana ticks. Anecdotal reports have implicated R. amblyommii in human 
disease but the majority of these conclusions have yet to be substantiated in laboratory 
studies [49-53].  
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Sample ID Tick species 
Accession 
number Homology 
S1AM1 A. maculatum KC003477 99% R. parkeri 
S1AM3, S1AM4 , S1AM5, 
S1AM6, S1AM8 A. maculatum KC003475 100% Candidatus R. andeanae 
S2AM3* A. maculatum KC003475 100% Candidatus R. andeanae 
S2AM3* A. maculatum KC003476 99% R. parkeri 
S2AM1, S2AM2, S2AM4 , 
S2AM5, S2AM6 A. maculatum KC003477 99% R. parkeri 
S3DV1, S3DV2  D. variabilis KC003477 99% R. parkeri 
S4AM1, S4AM2, S4AM3, 
S4AM, S4AM6, S4AM7, 
S4AM8, S4AM9 A. maculatum KC003477 99% R. parkeri 
S4DV1, S4DV2, S4DV3 D. variabilis KC003477 99% R. parkeri 
S5DV3 D. variabilis KC003477 99% R. parkeri 
S6AM1, S6AM3 A. maculatum KC003477 99% R. parkeri 
S6DV1 D. variabilis KC003477 99% R. parkeri 
S10AM1, S10AM2, S10AM3, 
S10AM4, S10AM5, S10AM6, 
S10AM7, S10AM8, S10AM9, 
S10AM10 A. maculatum KC003477 99% R. parkeri 
S10AM5, S10AM6 A. maculatum KC003475 100% Candidatus R. andeanae 
S11IS3* I. scapularis KC003478 99% R. parkeri 
S11IS2, S11IS3*, S11IS4 I. scapularis KC003474 
100% Rickettsial 
endosymbiont of I. scapularis 
S12IS1, S12IS2* I. scapularis KC003478 99% R. parkeri 
S12IS2* I. scapularis KC003471 99% B. burgdorferi 
S13IS1 I. scapularis KC003470 99% B. burgdorferi 
S14IS2 I. scapularis KC003472 
100% Rickettsial 
endosymbiont of I. scapularis 
S16AA1, S16AA2*, S16AA4 A. americanum KC003473 99% R. amblyommii 
S16AA2* I. scapularis KC003469 99% B. bissettii 
S17IS4 I. scapularis KC003472 
100% Rickettsial 
endosymbiont of I. scapularis 
S17IS3 I. scapularis KC003474 
100% Rickettsial 
endosymbiont of I. scapularis 
  
Table 2.2. Tick DNA samples positive by PCR in this study. Identical sequences are 
represented by identical accession numbers. DNA samples containing more than one 
bacterial species are denoted by asterisks. 
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This study was conducted retrospectively on ticks collected from bears by Louisiana 
department of Wildlife and Fisheries personnel. Due to various limitations the collected ticks 
probably do not comprise the total tick population on each bear. It is expected that immature 
stages of ticks were overlooked during sampling, as ectoparasite collection was not the focus 
of the fish and wildlife personnel’s work. In addition many of the female ticks collected and 
subjected to PCR were at different stages of engorgement, yet others had no obvious signs 
that a bloodmeal had begun. These limitations directly affect the interpretation of the data 
presented in that, while it is possible that detection of bacteria in these ticks may indicate 
infection, it is just as likely that these bacteria were imbibed during feeding on the host bear 
Figure 2.1. Location of ticks positive for bacterial DNA tested for in this study. 
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either by co-feeding transmission or by an infection in the bear. Future studies should 
ascertain infection status in questing; unfed, ticks in Louisiana. 
With the resurgence of zoonotic vector-borne diseases in the past three decades, the 
importance of disease surveillance and control has become apparent. In the US, the recent 
discoveries of tick-borne zoonotic pathogens like R. parkeri, Rickettsia spp. 364D, Ehrlichia 
muris-like (EML), Panola mountain Ehrlichia, and Powassan virus combined with the 
increasing frequency of tick borne diseases like Lyme disease, SFG rickettsiosis, 
anaplasmosis, ehrlichiosis and babesiosis has more than proven a need to closely monitor 
tick-borne diseases [54-57]. Since little is known about the organisms circulating in 
Louisiana ticks, detection of bacteria in ticks that commonly parasitize humans improves our 
understanding of tick-borne disease risks to human and animals in the state. The detection of 
R. parkeri and B. burgdorferi, and the novel association of R. parkeri with I. scapularis, in 
ticks collected from black bears prompts more questions on the prevalence of tick-borne 
pathogens in questing and other host-associated ticks across Louisiana. Surveillance of 
pathogens in human-biting ticks in Louisiana is essential to educating health professionals, 
elucidating tick-borne disease risk and ultimately protecting the health of the public. 
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CHAPTER 3. DETECTION OF LYME BORRELIA IN QUESTING IXODES SCAPULARIS 
(ACARI: IXODIDAE) AND SMALL MAMMALS IN LOUISIANA 
 
3.1. Abstract 
Lyme borreliosis is caused by spirochetes from the Borrelia burgdorferi sensu lato 
(s.l.) species complex. In the United States, B. burgdorferi sensu stricto (s.s.) (Johnson, 
Schmid, Hyde, Steigerwalt, and Brenner) is the most common cause of human Lyme 
borreliosis. With over 25,000 cases reported annually, it is the most common vector-borne 
disease in the US. While around 90% of cases are contained to the northeastern and Great 
Lake states, areas in Canada and some southern states are reporting rises in the number of 
human disease cases. Louisiana records a few cases of Lyme each year. While some are most 
certainly the result of travel to more endemic areas, there exists evidence of locally acquired 
cases. Louisiana has established populations of the vector tick, Ixodes scapularis (Say), and a 
wide variety of potential reservoir animals, yet Lyme Borrelia has never been described in 
the state. Using culture and polymerase chain reaction, we investigated the presence of Lyme 
Borrelia in both mammals and questing ticks at a study site in Louisiana. While culture was 
mostly unsuccessful, we did detect the presence of B. burgdorferi s.s. DNA in 6.3% (11/174) 
of ticks and 22.7% (5/22) of animal samples. To our knowledge this is among the first 
evidence documenting B. burgdorferi s.s. in Louisiana. Further investigations are required to 
determine the significance these findings have to human and animal health. 
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3.2. Introduction  
With over 25,000 human cases reported annualy, Lyme borreliosis is the most 
common vector borne diseases in the United States [1]. It is caused by spirochetes from the 
Borrelia burgdorferi sensu lato (s.l.) species complex (collectively referred to as Lyme 
Borrelia). In the US B. burgdorferi sensu stricto (s.s.) is the most common Lyme Borrelia 
spirochete implicated in human disease, its main vectors being Ixodes scapularis (Say) and I. 
pacificus (Cooley and Khols) [2]. The nymphal life stage of these ticks is overwhelmingly 
responsible for the majority of reported human cases [3]. Lyme borreliosis is a zoonotic 
disease and humans are considered dead end hosts, therefore reservoir hosts like mice, 
chipmunks and shrews are essential in perpetuating the spirochetes’ enzootic transmission 
cycle [4]. 
Although the majority of Lyme borreliosis cases occur in northeastern and Great 
Lakes states [1], areas not historically considered Lyme endemic are starting to report more 
cases. For example, researchers in Canada have mapped the encroachment of I. scapularis 
and subsequently Lyme Borrelia spirochetes over the past two decades [5, 6]. On the 
southern side of this expansion, states like Virginia are becoming Lyme “hotspots” with a 
reported 1300% increase in cases from 1997-2007 [7, 8]. Louisiana reported 133 cases of 
Lyme borreliosis from 1998-2011, however for many of these cases it is impossible to 
determine if the patient had actually acquired the infection in Louisiana or from travel to 
more Lyme endemic areas [9]. In 2012, a young child was diagnosed with Lyme borreliosis 
by physicians associated with Tulane Medical Center. This case met the Centers for Disease 
Control’s surveillance definition and had no history of travel outside the state (Black 2012; 
B.F.Leydet, personal communication). Like most other states in the southern US the lower 
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incidence of Lyme borreliosis in Louisiana is likely multifactorial.  While Lyme Borrelia 
spirochetes are endemic to many states in the South, differences from the traditional 
northeastern Lyme Borrelia ecology probably play a significant factor in human exposure 
and disease diagnosis. For example, host diversity in the South is higher, leading to more 
refractory hosts and changes in the vector’s ecology, multiple complex cryptic Lyme 
Borrelia cycles involving non-human biting ticks exist, and the population and overlap of 
Amblyomma americanum (L.) the vector of Southern-Tick Associated Rash Illness further 
complicates the situation [10-13]. These reasons amongst others likely play an integral role in 
the lower infection prevalence and significantly reduced human encounters with nymphal I. 
scapularis across the southern US [14, 15]. 
The spread of Lyme borreliosis highlights the importance of surveillance in areas 
once considered low risk. Surprisingly, even with established state-wide populations of I. 
scapularis [16], a plethora of potential reservoir hosts [17], and evidence that Louisiana 
populations of I. scapularis are competent vectors of B. burgdorferi [18], almost nothing 
exists in the literature regarding the presence of Lyme Borrelia in Louisiana. Therefore, this 
study investigated the presence of Lyme Borrelia in ticks and mammals at a site in 
Louisiana. 
3.3. Materials and Methods 
The study area chosen was Tunica Hills Wildlife Management Area in West Feliciana 
Parish, Louisiana.  Forest cover was categorized as upland hardwood rolling bluff land which 
supports a large population of animals including species of small rodents, birds, wild turkey, 
and white-tail deer. Questing ticks were collected by flagging with 1-m2 white felt cloth flags 
along defined hiking paths and animal trails. Flagging was conducted once or twice a week 
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for 2-3 hours throughout the year (2009-2010) but only I. scapularis were utilized in this 
study. Animal trapping was conducted when nymphal I. scapularis were expected to be 
feeding on hosts (from spring to early fall in 2010). Animals were trapped using Tomahawk 
live traps placed along animal tracks and trails. A total of thirty-three traps were set at night 
at least once a week during the aforementioned trapping period. This resulted in a total of 
1056 trap nights.  Captured animals were anesthetized with a combination of ketamine and 
dexmedetomidine, measured, weighed and sexed. Ectoparasites were removed and placed in 
tubes alive for later processing and identification using a standard key [19]. Two 2-mm ear 
punch biopsies (EPB) were taken, and blood was drawn for culture and PCR analysis. 
Animals were released at capture site following recovery from anesthesia. Borrelia culture 
isolation attempts were performed on blood, EPB, and questing ticks in BSK-H complete 
media (Sigma, St. Louis, MO) supplemented with rifampin 50 µg/ml, phosphomycin 50 
µg/ml and amphotericin B 2.5 µg/ml as previously described [20, 21]. An indirect 
immunofluorescence assay (IFA) was performed on cultures with evidence of spirochete 
growth utilizing monoclonal antibodies specific for B. burgdorferi (H5332) as previously 
described [22]. DNA extractions were performed on 2-mm EPBs from small mammals and 
half of each adult black-legged tick using the GeneElute Genomic DNA Miniprep kit 
(Sigma). EPBs and tick halves were minced by single use sterile scalpel and DNA extracted 
as directed by the manufacturer. PCR and thermocycling were performed with a nested 
primer set targeting a 389-bp portion of the chromosomally located  flaB gene as previously 
described [23]. Borrelia flaB PCR has been successful in the sensitive detection and 
delineation of B. burgdorferi s.l. species by sequence analysis of PCR products, from both 
field and culture samples [24-26]. Environmental controls utilized for detection of DNA 
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contamination in all experiments included simultaneous extraction tubes with no tissue added 
for all DNA extractions and molecular biology grade water used as a negative template in all 
downstream PCRs. PCR products were visualized by electrophoresis on a 2% agarose gel 
stained with ethidium bromide. PCR products were purified using the QIAquick PCR 
purification kit (Qiagen, Valencia, CA) following manufacturer’s instructions. LSU’s 
Biommed Gene Lab Bi-directionally sequenced the amplified PCR products. Sequences were 
aligned using CustalX and compared with existing sequences in the National Center for 
Biotechnology Information (NCBI) Genebank using the Basic Local Alignment Tool 
(BLAST) [27, 28]. In all aforementioned testing, appropriate positive controls included: a 
culture of clonal B. burgdorferi B31 (5A11) and extracted gDNA from the culture. Negative 
controls as previously described above repeatedly showed no evidence of contamination 
throughout this study. 
3.4. Results 
In total, 174 adult blacklegged ticks (I. scapularis), seven mice (Peromyscus spp.), 
six eastern wood rats (Neotoma floridana Ord), four raccoons (Procyon lotor L.), four 
eastern grey squirrels (Sciurus carolinensis (Gmelin) and one North American opossum 
(Didelphis virginiana Kerr) were screened by PCR and culture for evidence of Lyme 
Borrelia. PCR testing of ticks produced 11 (6.3%) borreliae sequences. Five (22.7%) of the 
animals had PCR positive EPBs; this included two mice (28.6%), a woodrat (16.7%), a 
raccoon (25%) and a squirrel (25%). No I. scapularis were collected from trapped animals. 
The 11 positive questing I. scapularis all had identical sequences (Table 3.1). Animal 
sequences shared some similarity with the ticks in one polymorphic site; however, other 
single nucleotide polymorphisms differed among samples. All sequences generated in this 
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study had nucleotide differences from B. burgdorferi strain B31, yet were 99% homologous 
when aligned (Table 3.1).  One tick and one squirrel sample produced spirochetes in primary 
culture isolates; however, upon multiple passages the samples were lost to bacterial 
contamination. Aliquots of these cultures were subjected to IFA in which they reacted to B. 
burgdorferi specific OspA H5332 antibodies.  These two cultures were also positive by PCR 
and had identical sequences to their respective tick half and EPB which were subjected only 
to PCR as previously described. 
3.5. Discussion 
Since 1998, Louisiana has recorded 133 cases of human Lyme borreliosis [9]. While 
a proportion of these are certainly acquired from travel to more Lyme endemic parts of the 
country, there is evidence for locally acquired cases. The enzootic cycle of B. burgdorferi has 
been well studied in areas of the Northeast, yet many states in the South continue to be 
understudied. Large scale US surveys have concluded that the prevalence of infected I. 
scapularis nymphs in the South is minuscule. However, these conclusions were based on 
very low numbers of ticks [12], and in Louisiana almost no work has been conducted 
investigating the presence of Lyme Borrelia. Conversely tick surveys across other southern 
states have identified B. burgdorferi infection in many populations of I. scapularis [29-37]. 
In addition to natural cycles of B. burgdorferi involving I. scapularis, cryptic cycles of Lyme 
Borrelia have been documented in southern states involving Ixodes affinis (Neumann), I. 
minor (Neumann) and I. dentatus (Neumann) transmitting multiple B. burgdorferi s.l. species 
[11, 38]. Competent reservoir animals dispersed across the southern US have been shown to 
be infected with multiple species of Lyme Borrelia [11, 32]. Several ecological surveys 
conducted in southern states have led to the discovery of new Lyme Borrelia species, 
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vectors, and reservoirs, which have expanded our understanding of Lyme Borrelia ecology 
[29, 30, 39].  
Along with a recent survey of ticks collected off black bears in Louisiana [40], these 
are the first records of B. burgdorferi in Louisiana ticks and wildlife. This discovery, while 
novel, was not unexpected. Like other southern states, the prevalence of B. burgdorferi in 
Louisiana ticks at our study site is lower (6.3%) than the more endemic areas in the Northeast 
where prevalence rates can be as high as 30-50% [12, 41, 42]. The lack of nymphal I. 
scapularis collected from animals and by flagging during this study is also consistent with 
reports from states across the southern US [43]. The decreased success in cultivating Borrelia 
from ticks and mammals in this study is a phenomenon seen in other studies outside areas of 
higher endemicity. Could this be due to a lower detection sensitivity of culture versus 
molecular methods [44]?  Or are Lyme Borrelia spirochetes in the South less likely to grow 
in traditional media [29]? While this remains unknown further studies are warranted. 
Because Louisiana consistently reports cases of human Lyme borreliosis each year, 
the detection of B. burgdorferi DNA in both vector ticks and competent reservoir hosts is 
significant. Nymphal I. scapularis are the main vector for B. burgdorferi in the eastern US, 
and while not detected in this study, can be found questing and attached to humans in 
Louisiana (B.L., unpublished data). It is also important to note that DNA evidence of bacteria 
does not confirm viability of the organism, and because cultures in this study were mostly 
unsuccessful, caution must be taken in the interpretation of these results. Still, molecular 
surveys demonstrating presence of a pathogen in known vectors and reservoirs are the critical 
first steps in our understanding of vector borne disease agents in different geographical areas.
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Table 3.1. B. burgdorferi flaB sequences amplified from mammalian and tick gDNA samples in this study 
Organism sampled Common name Homology to B. burgdorferi 
B31 (NC_001318.1) 
Nucleotide differences from B31                 
(basepair site of polymorphism) 
N. floridana  Wood rat 99% T→C (738) 
P. lotor  Raccoon 99% T→C (738) 
Peromyscus spp.  Field Mouse 99% T→C (510); T→A (687) & T→C (738) 
Peromyscus spp.  Field Mouse 99% T→C (738) 
S. carolinesis  Gray Squirrel 99% T→C (510); T→A (687) & T→C (738) 
S. hispidus  Cotton rat 99% T→C (738) 
I. scapularis 
(questing) 
Black-Legged Tick 99% T→C (738) 
*Sequence results aligned to the full (1011 basepairs) flaB portion of the B31 chromosome (positions 147649–148659) 
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More importantly, studies like this ultimately help relay new information to researchers and 
healthcare providers who in turn help educate the public. Evidence from this study should 
prompt further state-wide surveys investigating the prevalence of Lyme Borrelia in 
Louisiana ticks and wildlife. 
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CHAPTER 4. SIMILARITY OF BORRELIA BISSETTII AND BORRELIA BURGDORFERI 
SENSU STRICTO IN MURINE INFECTION AND IMMUNE RESPONSE 
 
4.1. Abstract 
Increasing numbers of Borrelia burgdorferi sensu lato (sl) species have been isolated 
in the United States since Borrelia burgdorferi sensu stricto (ss) was identified as the 
etiologic agent of Lyme disease.  To date, many of these species remain understudied, even 
with forthcoming evidence associating them with human illness. Using a murine model, we 
investigated the infectivity, virulence, and humoral immune response to a North American 
isolate of Borrelia bissettii by culture, molecular and serological methods. Original B. 
bissettii cultures were unable to infect immunocompetent mice, but were confirmed 
infectious after adaptation in immunodeficient animals. The ID50 of B. bissettii was more than 
two logs higher than that of B. burgdorferi ss.  Despite this, B. bissettii produced spirochete 
burdens similar to B. burgdorferi ss in skin, heart and bladder and only significantly lower in 
joint tissues.  Borrelia bissettii induced an antibody response similar to B. burgdorferi ss as 
measured by immunoblotting and the C6 enzyme-linked immunosorbent assay. This study 
contributes to our understanding on the potentially pathogenic B. bissettii spirochete. 
Infection dynamics of B. bissettii, and especially its induced humoral response, are similar to 
B. burgdorferi ss, suggesting that this species may also cause human infection.    
4.2. Introduction 
In 1982, the causative agent of Lyme disease was isolated from an Ixodes scapularis 
tick [1]. The bacterium, a gram-negative spirochete, was named Borrelia burgdorferi after 
Dr. Willy Burgdorfer, one of the researchers who identified it. Three decades after this 
discovery, advancements in molecular biology have led to the delineation of the B. 
burgdorferi sensu lato (sl) species complex [2]. This complex is currently made up of 19 
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named species distributed around the globe [3, 4]. While genetically similar, many of these 
bacteria occur in specific tick-vertebrate enzootic cycles [5]. Some vector ticks commonly 
contact humans [6]; but, many of these Borrelia enzootic cycles involve ticks that rarely bite 
humans, which subsequently leaves the pathogenicity of many B. burgdorferi sl species in 
question [7, 8]. 
In 2011, 33,000 cases of human Lyme disease were reported to the Centers for 
Disease Control (CDC) [9]. However, the CDC has announced they estimate this statistic is 
well below the actual number of diagnosed cases (~300,000/year) [10]. Seven B. burgdorferi 
sl species have been culture isolated in North America [2]. Yet, only B. burgdorferi ss is 
widely considered responsible for cases of human Lyme disease in the US [2]. One of the 
species, Borrelia bissettii, is found overlapping the distribution of B. burgdorferi ss in the US 
and also in areas of Europe. Borrelia bissettii is phylogeneticly closely related to the human 
pathogenic B. burgdorferi ss species [11]. To date, three studies have demonstrated 
molecular detection of B. bissettii [12-14] in human clinical samples. Borrelia bissettii 
infection and pathology have been previously reported in laboratory animals [15, 16]; but, 
apart from these and general molecular surveys in ticks and wildlife, our understanding of B. 
bissettii, as well as the majority of non-B. burgdorferi ss in the US, is infantile at best.  
Diagnosis of Lyme disease is an evolving field, often based on a combination of 
clinical signs (i.e., erythema migrans, facial palsy, and major joint arthralgia), exposure to 
vector ticks in endemic areas, and serological diagnostic tests [17].  It is well understood that 
B. burgdorferi sl spirochetes can cause a variety of clinical signs [18, 19], overlap 
geographically [4, 8], and have differential reactivity with serological diagnostic tests [20, 
21]. Initial diagnostic tests (enzyme-linked immunosorbent assays, and IgM/IgG 
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immunoblots) were designed based on the B. burgdorferi ss organism; however, with our 
increased understanding of the genetic diversity of this species complex, many of these tests 
are proving to be less effective in their diagnostic abilities. This can be attributed to the 
highly diverse repertoire of Borrelia immunogenic proteins [22], ipso facto, studies have 
shown that utilization of multiple species in these serological tests greatly increases 
sensitivity [25-28]. If in North America multiple B. burgdorferi sl spirochetes have the 
potential to cause human illness, it is essential we have a complete understanding of their 
infection course and induced immune response in well characterized animal models.  
In this study, we compared B. bissettii and B. burgdorferi ss infection in a murine 
model by examining the ID50 value, tissue bacterial load, and immune response.  Although B. 
bissettii had a much higher ID50 value than B. burgdorferi ss, infection generated similar 
bacterial load between the two in most types of tissues examined.  Moreover, B. bissettii 
induced a similar humoral response as B. burgdorferi ss. 
4.3. Methods 
4.3.1. Borrelia Species 
 Low passage (≤ 5) B. burgdorferi strain B31 (5A11) and B. bissettii strain CO275 
were grown in Barbour-Stoenner-Kelly (BSK-H) complete (Sigma-Aldrich) media with 
supplemented antibiotics as previously described (Borrelia strain descriptions can be found 
in appendix) [23]. Borrelia burgdorferi B31 (5A11) is a clonal isolate from the original B. 
burgdorferi isolated from an I. scapularis, this clone has the full repertoire of 21 plasmids 
[24]. Borrelia bissettii CO275 is a bacterial isolate from a Neotoma mexicana in Colorado 
[25]. 
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4.3.2. Murine Inoculation 
Initially, six week old male C3H/HeJ (Jackson Labs) mice were randomly allocated 
into three groups of five mice. Intradermal inoculations were done in the caudoventral 
abdomen just right of midline with 106 mid-log phase Borrelia. Groups were inoculated with 
either B. bissettii, B. burgdorferi or BSK-H. Infection was allowed to develop for four weeks 
after which mice were humanely euthanized. Blood (intracardiac) and tissues (skin, heart, 
bladder and joint) were taken for subsequent serology, culture and qPCR. Tissues were 
cultured as previously described [26] and monitored weekly for eight weeks by dark-field 
microscopy for evidence of spirochete growth. Three BALB/c scid mice were inoculated 
with B. bissettii culture as described above. After three weeks, mice were sacrificed and 
tissues (ear punch, inoculation site, and heart) were cultured as previously described [26]. 
Cultures were grown up to mid-log phase and these host adapted spirochetes were utilized to 
repeat the experiment in immunocompetent C3H/HeJ mice increasing numbers of mice to 15 
for B. bissettii. Animal procedures were approved by Louisiana State University’s 
Institutional Animal Care and Use Committee. 
4.3.3. ID50 Determination 
Host adapted spirochetes were grown in culture as mentioned above. Cultures were 
10-fold serially diluted in BSK-H media. Twenty mice were randomly allocated into four 
groups. Mice were inoculated with a single dose of spirochetes suspended in 100 µL of BSK-
H. Doses ranged from 103 to 106 spirochetes. Mice were monitored for infection by culture of 
ear punch biopsies weekly for four weeks. Mice were then sacrificed and tissues were 
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subjected to culture. The ID50 values were calculated by the method of Reed and Muench 
[27]. 
4.3.4. DNA Extraction and qPCR 
Mice tissue samples were subjected to gDNA extraction using GeneElute Genomic 
DNA Miniprep kit (Sigma) following manufacturer’s supplied protocol. Extracts were stored 
at -20˚C until qPCR was performed. Primers and probes (Table 4.1) for B. burgdorferi and B. 
bissetii were developed based on known sequences of the decorin binding protein B (dbpB) 
gene located on lp54 (a single copy linear plasmid essential for the borrelia infectious cycle). 
Mouse primers and probes were adapted from Grasperge et al. (2012) [28]. qPCR reactions 
were set up in a 96-well plate; each reaction consisted of 17.5 µL of 2X Maxima Probe qPCR 
Master Mix (Thermo Scientific), 200 nM of each Borrelia dbpB primer and probe, 8 5nM of 
each mouse cfd primer, 200 nM of mouse cfd probe; molecular biology grade water, and 5 
µL of template DNA.  
 
Reactions were transferred in triplicate-10 µL aliquots to 384-well plates for subsequent 
qPCR. Standard curves for quantification were based on 10-fold serial dilutions of single 
copy gene plasmids. Plasmid constructs for standard curve serial dilutions were assembled 
Primer Name Sequence Reference 
BbdbpB-F 5’-GGCTAGTCCACCACTTGTTACC-3’ This Study 
BbdbpB-R 5’-GCAGCTCTTGAATCGTCCTC-3’ This Study 
BbdbpB-Probe 5’-Cy5-CACCTTTTCCCGTGGCTTCTT-3’ This Study 
BbissdbpB-F 5’-AAACGCACTCCCTTGTCAG-3’ This Study 
BbissdbpB-R 5’-GGTTGCATGTAACGTTGGAC-3’ This Study 
BbissdbpB-
Probe 
5’-HEX-TCCCTAGAAGATGATTCAAGCGC-3’ This Study 
CFD1461 5’-CAGTTTCTTGCTGGCTATTGG-3′ 26 
CFD1570 5′-CCACGTAACCACACCTTCG-3′ 26 
CFD-Probe 5’-(6)FAM-TAGTGGCCCTGCCCTA-3’ 26 
Table 4.1. qPCR Primers and probes utilized in this study 
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following methods previously described [29]. qPCR was performed with a Roche Lightcycler 
480i. Thermocycling protocol included an initial denaturation step for 10 mins at 95˚C, 
followed by 40 cycles of a denaturation step for 15 sec at 95˚C and a 60 sec at 60˚C 
annealing step. Analysis of the reaction was conducted with the LightCycler 480i software. 
4.3.5. C6 Peptide Enzyme-Linked Immunosorbent Assay (ELISA) 
Individual infected mouse serum (diluted 1:200) was tested by C6 ELISA as 
previously described [30]. A TMB ELISA development kit (Kirkegaard & Perry laboratories) 
was utilized according to manufacturer’s directions, and optical density (OD) values were 
measures at 450 nm on an ELISA plate spectrophotometer. Cutoff OD was defined as the 
mean OD ± 3 standard deviations of the negative control mice sera. All samples were 
assessed in duplicate and averaged ODs are reported.  
4.3.6. Immunoblots 
Immunoblots of whole cell B. burgdorferi B31 fractionated proteins were 
accomplished with the MarDx Marblot IgG kit (Trinity Biotech) following manufactures 
instructions with minor modifications. This included utilizing individual infected mouse sera 
as the primary antibody (1:200 dilution) followed by incubation with 1:1000 goat-anti mouse 
alkaline phosphatase labeled IgG (Kirkegaard and Perry Laboratories). 
4.3.7. Characterization of B. bissettii (CO275) by Next Generation Sequencing 
Borrelia bissettii spirochetes isolated from BALB/c scid mice were subjected to next 
generation sequencing on the Ion Torrent PGM platform utilizing a 316 chip, followed by 
denovo assembly with MIRA 4.0 [31]. MIRA processed 3,763,285 reads which produced 
816 contigs with an average coverage of 150x. Contigs generated were then aligned to a 
reference genome (B. bissettii DN127; NC_015921) using Geneious version 7.1.2 this 
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resulted in 352 contigs mapped to the reference chromosome which provided almost 
complete coverage (99.6%) and a 98.5% homology. Protein coding regions (CDS) of the 352 
chromosome contigs were identified and annotated by the NCBI Prokaryote Genome 
Annotation Pipeline (http://www.ncbi.nlm.nih.gov/genome/annotation_prok/) and deposited 
in NCBI WGS server (Accession JNBW00000000). Non-chromosome contigs were aligned 
to B. burgdorferi B31 plasmids (NC_000948-000957, NC_001903-001904 and NC_001849-
001857) and open reading frames (ORFs) were predicted with the program GLIMMER [32]. 
Geneious aligner was utilized to pairwise align and compare known B. burgdorferi B31 host 
associated virulence determinates with B. bissettii CO275 homologs. 
4.3.8. Statistical Analysis 
Data were analyzed by Kruskal-Wallis with Dunn’s Multiple Comparison in 
GraphPad Prism version 5.00 for windows (GraphPad Software). P values ≤ 0.05 were 
considered significant. 
4.4. Results 
4.4.1. Borrelia bissettii is Able to Infect Immunocompetent Mice Only After Adaptation in 
Immunodeficient Mice 
 
The initial infection study was performed by intradermal inoculation of C3H/HeJ 
mice with a single dose of 106 spirochetes of B. bissettii or B. burgdorferi ss grown from 
frozen stock cultures.  As shown in Table 1, all the five mice that were inoculated with B. 
burgdorferi ss developed infection.  In contrast, none of the mice that received B. bissettii 
produced a positive tissue cultures indicating that B. bissettii, in at least in this phase and 
form, are unable to infect immunocompetent mice (Table 4.2). 
Borrelia bissettii was shown infectious in past studies [16, 33].  Lose of infectivity 
could result from long term storage [34].  To restore infectivity in immunocompetent mice, 
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cultured B. bissettii was first inoculated into BALB/c scid mice.  As shown in Table 4.2, all 
tissues examined became positive four weeks post inoculation.  Next, B. bissettii isolated 
from infected scid mice was utilized to infect immunocompetent mice.  Like mice that were 
inoculated with B. burgdorferi ss, all mice inoculated with host adapted B. bissettii became 
infected (Table 4.2), indicating that B. bissettii infectivity was restored after adaptation in 
immunodeficient animals.  
The original B. bissettii isolate used in this study was a low passage stock culture, 
which had never been subcloned. Because of the potential for a highly herterogeneous 
population of borreliae, passage through scid mice allowed us to select for a more 
homogenous population of infectious spirochetes, which we confirmed by next generation 
sequencing. 
 
 
Experiment Inoculum 
(106 cells) 
 
No. of positive specimens/no. of samples 
examined 
All 
Tissues 
No. of 
infected 
mice/no. 
of mice 
inoculated 
Ear Skin Heart Bladder Joint 
1 B. bissettii 0/5 0/5 0/5 0/5 0/5 0/20 0/5 
B. burgdorferi ss 5/5 5/5 4/5 5/5 5/5 24/25 10/10 
2 B. bissettii 3/3 ND 3/3 ND 3/3 9/9 3/3 
3 B. bissettii 15/15 15/15 11/15 15/15 13/15 69/75 15/15 
B. burgdorferi ss 5/5 5/5 5/5 5/5 5/5 25/25 5/5 
* Experiment 1: Ten C3H/HeJ mice were inoculated with 106 cells of original B. bissettii 
(n=5) or B. burgdorferi ss (n=5) cultures. Experiment 2: Three BALB/c scid mice were 
inoculated with 106 cells of B. bissettii. Experiment 3: Twenty C3H/HeJ mice were 
inoculated with 106 cells of either host-adapted B. bissettii cells isolated from scid mice 
(n=15) or infectious B. burgdorferi ss (n=5). Ear, skin (inoculation site), heart, bladder 
and joint specimens were collected four weeks post-inoculation, cultured for spirochetes 
and monitored for bacteria growth for eight weeks. ND, not determined. 
 
Table 4.2. Borrelia bissettii is able to establish infection in immunocompetent mice only after 
adaptation in immunodeficient mice. 
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4.4.2. Borrelia bissettii Infection Produces Similar Bacterial Loads in Skin, Heart and 
Bladder Tissues as B. burgdorferi ss but Lower Burdens in Joint Tissues  
 
Tissue bacterial load was estimated by qPCR to compare virulence between B. 
bissettii and B. burgdorferi ss. 
After four weeks, tissues (skin, heart, urinary bladder and joint) were harvested for DNA 
extraction from 15 C3H/HeJ mice infected with B. bissettii and 10 mice infected with B. 
burgdorferi ss. As shown in Figure 4.1, B. bissettii infection led to similar bacterial load as B. 
burgdorferi ss infection in skin, heart and bladder tissues. However, B. bissettii burdens were 
significantly lower in joint tissues (Figure 4.1).  
 
Figure 4.1. Borrelia bissettii infection generates similar bacterial loads in skin, heart and 
bladder tissues as B. burgdorferi ss but lower spirochete burdens in joint tissues. Twenty 
five C3H/HeJ mice were inoculated with 106 spirochetes of either host-adapted B. 
bissettii (n=15) or infectious B. burgdorferi ss (n=10) and sacrificed a month later.  Skin 
(inoculation site), heart, bladder and joint specimens were harvested for DNA extraction 
and analyzed for tissue bacterial load by qPCR.  The bacterial load is presented as dbpB 
gene copy number (copies of extracted gDNA, cegd) per 104 mouse cells. Data were 
analyzed by Kruskal-Wallis with Dunn’s Multiple Comparison. Error bars define SEM 
and asterisks denote significance p ≤ 0.05.  (C0275= B. bissettii, B31= B. burgdorferi). 
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4.4.3. The ID50  Value of B. bissettii is Higher than B. burgdorferi ss 
 ID50 was determined as a measurement of B. bissettii virulence in the murine host.  
As shown in Table 4.3, the ID50 value was approximately 2.4x10
4 organisms.  This represents 
at least a 100-fold higher ID50 than B. burgdorferi, whose ID50 has been estimated at >200 
organisms in numerous studies conducted by different groups including us [35-38].  
4.4.4. Borrelia bissettii Elicits a Similar Murine Antibody Response as B. burgdorferi ss  
 Murine humoral immune response was analyzed and compared between B. bissettii 
and B. burgdorferi ss using a Lyme IgG immunoblot (Mardx Marblot).  This commercial kit 
was chosen as it is commonly utilized in Lyme serology. As shown in Figure 4.2, similar 
banding patterns were detected in serum from mice regardless of Borrelia infection. 
Accordingly, when recommended diagnostic criteria were applied, as the manufacturer 
instructs, all infected mice were diagnosed as positive by Lyme serology.  
 
Inoculum 
(No. of 
cells) 
No. of culture positive samples/no. of 
specimens examined No. of infected 
mice/no. of 
mice 
inoculated 
ID50 (no. of 
cells) 
Ear 
 
Skin 
 
Heart 
 
Joint 
 
103 0/5 0/5 0/5 0/5 0/5 
2.4X104 
104 1/5 1/5 0/5 1/5 1/5 
105 5/5 0/5 0/5 0/5 5/5 
106 5/5 4/5 2/5 2/5 5/5 
Table 4.3. ID50 Determination of B. bissettii 
 
* Twenty C3H/HEj mice were inoculated with serial dilutions of host adapted B. bissettii 
cultures. Ear punches were cultured and monitored weekly for spirochete growth. All mice 
were sacrificed four weeks post inoculation and tissues were cultured and monitored by dark 
field microscopy for eight weeks for evidence of bacterial growth. The ID50 values were 
calculated by the method of Reed and Muench [25]. 
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4.4.5. Borrelia bissettii Elicits an Anti-C6 Antibody Response During Murine Infection  
As all B. burgdorferi sl species identified, to date, as Lyme disease agents induce a 
strong C6 antibody response [39], the anti-C6 antibody response to B. bissettii infection was 
analyzed. As shown in Figure 4.3, the specific antibody response was strong in all mice 
infected with B. bissettii, indicating that the C6 ELISA also can detect infections with these 
particular species. 
 4.4.6. Borrelia bissetti Possess Homologous Genes of Many Major B. burgdorferi ss 
Virulence Determinates 
 
The anti-C6 response demonstrated that B. bissettii must harbor a vlsE gene, but 
genomic data available for this species lack such a gene [40].To address this issue, DNA was 
prepared from our infectious isolate, and next generation sequencing was performed on the 
Ion Torrent PGM platform. In addition to a vlsE gene, many other critical virulence genes, 
such as ospAB, dbpAB, bbk32, p66, ospC, crasp1, crasp2, and multiple erps were found 
within the genome (Table 4.4). 
Figure 4.2. Borrelia bissettii humoral response is similar to B. burgdorferi ss during 
murine infection. Serum samples were collected from mice inoculated with 106 of either 
infectious B. burgdorferi ss (Lane 1 and 2) or host adapted B. bissettii (Lane 3-7) cultures 
four weeks post inoculation and analyzed for specific immune response using a 
commercial IgG immunoblot (MarDx Marblot) 
Approximate kDa 
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4.5. Discussion 
Areas in Eurasia experience first-hand the complexity that multiple pathogenic 
Borrelia can add to the epidemiology of human Lyme disease. With the forefront of 
molecular technologies, our initial understanding of this pathogen has drastically changed 
[2]. While these advances can work in our favor, in many ways they also complicate the 
situation. The idea of one spirochete species, B. burgdorferi, being the sole cause of human 
Lyme was challenged in Europe. European cases of human borreliosis have clinical 
manifestations that present differently when compared to Lyme cases in the US [41, 42]. In 
addition, spirochetes isolated from vector ticks and humans infections showed phenotypic 
differences when compared to B. burgdorferi [42]. Eventually multiple Borrelia species, 
most notably B. afzellii and B. garinii, were identified as additional spirochetes capable of 
causing human illness in Eurasia [2]. Subsequently, serological tests initially developed  
Figure 4.3. Borrelia bissettii induces an anti-C6 antibody response similar to B. burgdorferi ss 
during murine infection. Sera were collected from mice inoculated with 106 of either host 
adapted B. bissettii (n=15) or infectious B. burgdorferi ss (n=10) cultures four weeks post 
inoculation and analyzed for anti-C6 antibody by ELISA. Dotted line indicates a cutoff value 
as defined by the mean OD plus 3 standard deviations obtained from 10 sham inoculated 
mice. 
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Borrelia 
burgdorferi B31 
Gene 
CO275 Contig 
Location 
Nucleotide Pairwise 
Homology 
(%) 
bbk32 c1220 94.6 
crasp1 c303 68.5 
crasp2 c1369 97.7 
dbpA c171 77.9 
dpbB c151 83 
erpG c265 78 
erpK c16 74.2 
erpP c155 77.3 
ospA c310/1165 89.3 
ospB c1166 84.8 
ospC c183 82.7 
p66 c24 94 
vlsE c233 82 
against North American B. burgdorferi ss were found to be less effective in detecting 
confirmed human borreliosis cases in these same areas [20, 21]. The United States, like 
Eurasia, has a diverse Borrelia fauna. While B. burgdorferi ss certainly accounts for the 
majority of human borreliosis cases [43], current serological methods have not been 
sufficiently evaluated with respect to their efficacy in detection of non-B. burgdorferi ss 
North American Borrelia infections It is also unknown what, if any, clinical presentations 
would be encountered in a non-B. burgdorferi ss North American borreliosis infection. What 
is known is that many areas, while not endemic for B. burgdorferi ss, do have an abundance 
of other B. burgdorferi sl species [4, 8]. In this study, we describe murine infection and 
antibody response to B. bissettii, a widespread yet understudied Borrelia species. 
Table 4.4. Borrelia bissettii CO275 contains many homologous genes to B. burgdorferi 
B31 host virulence determinates 
*Contigs were mapped to B. burgdorferi B31 plasmids and ORFs were identified utilizing 
the program GLIMMER. Geneious aligner was utilized to compute pairwise alignment. 
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Interestingly, we were unable to infect immunocompetent mice with the B. bissettii 
culture grown directly from low passage frozen stocks. Because this isolate had been utilized 
in previous studies and was successful in murine infection [16, 33], we passed the cultures 
through immunodeficient scid mice to determine if over time these isolates had lost their 
infectious phenotype. The isolate caused disseminated infections in scid mice and re-isolated 
spirochetes were utilized successfully in repeat experiments with immunocompetent mice. 
This phenomena had never been experienced in our laboratory, but loss of infectivity after 
long term Borrelia storage has been described by at least one other research group [34].  This 
isolate had been in cold storage for over 15 years. Similarly, virulence associated plasmid 
loss has been described after long term storage of Bacillus anthracis [44]. In this study, by 
passing spirochetes through scid mice, we were able to restore the ability to infect 
immunocompetent animals. The objective of this study was not to investigate the reason 
behind this finding; however, the exact mechanism does warrant further study and this 
finding should be taken into consideration by researchers planning to utilize Borrelia isolates 
that has been stored for an extended period of time.  
Borrelia bissettii like B. burgdorferi ss has been shown to cause similar pathology in 
murine hosts.  This includes similar lymphocytic accumulations in the bladder interstitium, 
mononuclear cell infiltrates into great vessels and myocardium, resulting in atrial 
inflammation and myocardial necrosis and less commonly mild inflammation and lesions in 
the femorotibial joint [16]. Spirochete burdens reported in this study support the pathological 
findings reported by Schneider et al. Borrelia bissettii disseminates to tissues and has similar 
spirochete burdens compared to B. burgdorferi ss in the skin, heart and urinary bladder; yet, 
colonizes the joint tissues at lower numbers. Similar burdens seen in both the urinary bladder 
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and heart substantiate pathology seen in murine models of both Borrelia infections. 
Decreased joint burdens described in this study attest to the variable signs of joint pathology 
seen in a previous B. bissettii pathology study [16]. Spirochete burden data also supports 
evidence of human manifestations of B. bissettii infection which include reports of B. 
bissettii DNA detection in a cardiac tissue biopsy of a Lyme borreliosis case and in multiple 
instances, human serum [12-14]. Our findings, as well as growing literature reporting the 
pathogenic potential of Borrelia bissettii, demands further investigation. 
Much research has been targeted at developing better diagnostic tests for human 
Lyme borreliosis infection. Current serological diagnostic methods recommended by the 
Infectious Disease Society of America consist of a two-tier approach [45]. This includes a 
Lyme whole cell ELISA followed by an IgM/IgG immunoblot. Another serological test, the 
C6 ELISA, has been shown to be comparable if not more reliable than the current two-tier 
testing approach [46-48]. Initial serological tests were directed towards detecting one species, 
B. burgdorferi ss, of the B. burgdorferi sl complex. However, the expanding role of other 
species in human illness has led to serological tests, especially in Eurasia, that utilize 
multiple B. burgdorferi sl species to better facilitate diagnosis [49, 50]. This has been shown 
to increase sensitivity and specificity of these tests in areas endemic for multiple human 
pathogenic borreliae [49, 50]. In this study, we investigated the ability of a Lyme IgG 
Immunoblot and the C6 ELISA to detect infection in our B. bissettii murine model.  First, we 
assessed the ability of an FDA approved immunoblot test to detect B. bissettii infection in 
mice. Our results indicate that B. bissettii infected mice had similar immunoblot results 
compared to mice infected with B. burgdorferi ss. Therefore, murine infections with B. 
bissettii elicit an antibody response that is cross reactive with many B. burgdorferi ss 
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antigenic proteins. The second test we evaluated was the C6 peptide ELISA test. It is based 
on a 26-mer amino acid peptide developed against an invariant region (IR6) of the well-
studied virulence associated outer surface vlsE protein [30]. This peptide was created against 
the B. burgdorferi ss vlsE protein sequence but has been shown to be conserved among the 
three major pathogenic Borrelia spp. (B. burgdorferi ss, B. afzelii and B. garinii); and, during 
infection with many of these species mice elicit a positive anti-C6 antibody response [39]. In 
our study B. bissettii infected mice elicited a similar anti-C6 antibody response as did mice 
exposed to B. burgdorferi ss. This is the first report of a North American B. burgdorferi sl 
species other than B. burgdorferi ss eliciting a mammalian anti-C6 antibody response. 
Considering the endemicity of B. bissettii in many states and a recent study [51] reporting 
canines in Colorado testing positive by a diagnostic C6 snap test; it is likely, contrary to the 
authors’ conclusion, that these animals were exposed to and or infected by B. bissettii, further 
supporting the pathogenicity of this species of Lyme Borrelia.  
With the continued development of next generation sequencing, the ability to identify 
similarity between bacterial species is becoming easier, faster and more cost effective. 
Because the only B. bissettii genome sequenced to date was lacking the vlsE gene and lacks 
experimental infection data, we subjected our isolate to next generation sequencing. We 
confirm the species identity of B. bissettii CO275 and identify homologs to many major B. 
burgdorferi B31 host associated virulence genes supporting the infectious phenotype seen in 
our laboratory studies. 
 Our results confirm that B. bissettii has the ability to cause disseminated infections in 
mice [15, 16, 33, 52]. More importantly, this is the first report of spirochete infection loads 
and anti-C6 antibody response during infection with B. bissettii. These data also describe the 
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ability of current serological tests to detect murine infection of B. bissettii. In mice, B. 
bissettii can cause a disseminated infection, and based on two serological diagnostic tests, 
has similar antibody profiles to B. burgdorferi ss infections. While the murine model is the 
first step at determining infectivity of B. bissettii to mammals, it by no means implies these 
organisms are infectious to humans; however, there is growing evidence that B. bissettii may 
cause human and possibly canine illness. Based on our work, current serological test are 
unable to distinguish between these two infections in mice. Future studies should assess 
specific antigenic profiles shared by B. bissettii and B. burgdorferi ss to facilitate detection of 
specific Borrelia infections. More human-like animal models, such as the non-human 
primate model, could be utilized to determine what, if any, clinical signs B. bissettii 
infections would manifest in humans. The spectrum on Lyme disease is changing; to combat 
this global complex of emerging and potentially emerging bacterial infections, we must fully 
understand the scope of the problem. Future work should be directed at assessing the ability 
for each B. burgdorferi sl species’ potential to cause illness in humans. 
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CHAPTER 5. IXODES SCAPULARIS IS ABLE TO ACQUIRE YET UNABLE TO 
TRANSMIT BORRELIA BISSETTII TO MICE 
 
5.1. Abstract 
It is estimated that 300,000 cases of human Lyme borreliosis occur annually in the 
United States. Although the US is home to a diverse fauna of Lyme Borrelia species, only 
one is considered responsible for human disease. However, evidence is surfacing implicating 
other species in human illness. And, while much research has focused on the Borrelia 
burgdorferi sensu stricto (ss)-tick interface, tick vectors for most of the other North 
American Borrelia species still remain unknown. In this study we assess the ability of Ixodes 
scapularis to acquire and transmit Borrelia bissettii, a potential human pathogen, in a murine 
model. Borrelia-free I. scapularis larvae were allowed to feed on mice with disseminated 
infections of B. burgdorferi ss or B. bissettii. Ticks that molted were then allowed to feed on 
naïve mice to assess for transmission. Additionally, ticks were collected at multiple time 
points throughout the experiment and spirochete infection and burdens were assessed by 
culture and qPCR. Although I. scapularis acquire B. bissetii spirochetes at similar 
proportions as B. burgdorferi ss, spirochete burdens were significantly lower in B. bissettii 
infected ticks. Furthermore, I. scapularis is unable to transmit infection to naïve animals. 
And although a single animal showed some evidence of spirochete exposure, serology 
supported the finding that infection did not develop in these animals. In the tick, B. bissettii 
spirochete levels modestly increase throughout the tick’s developmental cycle until the adult 
stage where infection is not evident. Borrelia burgdorferi ss, unlike B. bissettii, underwent an 
exponential increase in spirochete numbers during the nymphal blood meal and retained 
similar infection levels as adults. In this model, Ixodes scapularis was unable to support B. 
bissettii throughout its life cycle, and while viable spirochetes can be detected in B. bissettii 
105 
 
infected ticks fed on naïve mice, infection is not transmitted. These data implicate another 
tick as the primary vector for B. bissettii in the eastern and southern US. However, this 
unique model may help assess details of the Borrelia-tick interface. 
5.2. Introduction 
Lyme borreliosis is a tick-borne zoonotic disease caused by spirochetes from the 
Borelia burgdorferi sensu lato (sl) genocomplex (collectively referred to as Lyme Borrelia). 
Spirochetes in this complex are responsible for an estimated 300,000 cases of human disease 
a year in the United States and at least another 85,000 cases a year in Europe [1, 2], making 
Lyme borreliosis the most common arthropod-borne disease in the Holarctic regions of the 
world [3, 4].  
Nineteen species make up the B. burgdorferi sensu lato complex [5]. Lyme Borrelia 
spirochetes are transmitted by ticks from the Ixodes ricinus complex and are dependent on 
both ticks and reservoir hosts to perpetuate in natural enzootic cycles [6]. Not all B. 
burgdorferi sl species are associated with human disease; to date, 12 species are confirmed or 
probable human pathogens [5, 7]. Of the Lyme Borrelia associated with or known to cause 
human disease, generally, one of five species are most often implicated in human infection. 
Yet, Borrelia afzellii, Borrelia garinii, and B. burgdorferi sensu stricto (ss) are responsible 
for the majority of human Lyme borreliosis around the world [8]. Borrelia burgdorferi ss is 
distributed worldwide, while B. afzellii and B. garinii are solely old world pathogens [8]. 
Seven species of Lyme Borrelia are endemic to the United States [9]. However only, 
Borrelia burgdorferi ss, is considered responsible for human cases of Lyme borreliosis [10]. 
Three decades after the discovery of the Lyme Borrelia complex, our understanding of this 
group of bacteria is still limited. Research has been focused intensely on the three major 
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human pathogenic species, especially B. burgdorferi ss, while the remaining 16 species 
remain understudied. As the Borrelia species complex keeps expanding, little work is done to 
identify the pathogenic potential and vectors for newly discovered and described species. 
This leaves a critical gap in our grasp of the epidemiology of Lyme borreliosis. In the United 
States, 95% of human Lyme borreliosis cases occur in the Northeast and Great Lake states 
where the organism responsible is B. burgdorferi ss and the vector is Ixodes scapularis [10]. 
However, cases also occur in many other areas of the US [11], including states where B. 
burgdorferi ss has yet to be described.  
One of the understudied North American Lyme Borrelia species is Borrelia bissettii. 
Borrelia bissettii was first isolated in 1987 by Bissett and Hill, and like many of the Lyme 
Borrelia spirochetes, was first described as an atypical B. burgdorferi ss strain [12]. It was 
not until 1998 that this atypical group of spirochetes received formal designation as a 
separate Borrelia species [13]. The range of this group of spirochetes is quite large, and like 
B. burgdorferi ss can be found both in the New and Old World [14]. Borrelia bissettii 
spirochetes have also been detected in many states across the US, including SC, GA, FL, MI, 
LA, CO, NC and CA [15-20]. Both Ixodes pacificus and I. spinipalpus have been 
experimentally demonstrated to be competent vectors to vertebrates; however, the ability of I. 
scapularis has only been suggested in the literature [21, 22]. Borrelia bissettii has been 
described in hosts including small rodents and lizards [13, 17, 22].  A few studies have 
investigated B. bissettii in experimental murine models [21, 23]. Mice develop pathology 
within the bladder, heart and occasionally in the femorotibial joint in similar ways as B. 
burgdorferi ss [23]. Borrelia bissettii-like spirochetes have been isolated from human 
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patients in Europe, and detected by polymerase chain reaction in serum, blood, skin and 
cardiac tissue in both the US and Eastern Europe [24-27]. 
Ixodes scapularis is arguably the most important human biting tick in the United 
States, serving as a vector for at least five tick-borne zoonosis. Even with recent evidence 
associating B. bissettii with human illness [24-28], detection of the organism in field 
collected ticks [16, 18-20, 22, 29-32], and the similarities between B. burgdorferi ss and B. 
bissettii infection in animal models, there exists no experimental evidence implicating I. 
scapularis as a vector for B. bissettii. This study tests the hypothesis that I. scapularis is able 
to acquire B. bissettii from, and subsequently transmit B. bissettii to a susceptible murine 
host.  
5.3. Materials and Methods 
5.3.1. Mice 
C3H-HeJ mice, obtained from Jackson laboratory, were utilized in this experiment. 
All mice were 5-week-old males and were housed in microisolator cages with HEPA filtered 
air. Both food and water were provided ad libitum. All animal research was approved by the 
IACUC at Louisiana State University. 
5.3.2. Borrelia Culture Preparation 
 Frozen stocks of low passage B. burgdorferi strain B31 and B. bissettii strain CO275 
were cultivated in Barbour Stoenner Kelly (BSK-H) complete media (Sigma) supplemented 
with antibiotics and fungicide as previously described [33]. Cultures were grown to a 
concentration of 106 spirochetes per mL, centrifuged for 10 minutes at 10,000xG, 
resuspended in 100 µL of BSK-H and utilized for mouse inoculation. Original B. bissettii 
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cultures were inoculated into BALB/c scid mice and re-isolated for use in immunocompetent 
mouse infection experiments, as described in the previous chapter. 
5.3.3. Mouse Infection 
For initial infections, 15 mice were randomly assigned to three groups consisting of 
five mice. Intradermal inoculations were done in the caudoventral region of the abdomen just 
right of midline with a 27G syringe and 100µL of inoculum. Group 1 mice were inoculated 
with B. burgdorferi ss spirochetes. Group 2 mice were inoculated with B. bissettii 
spirochetes. Mice in group 3 served as a control and were inoculated with only BSK-H 
media. Infections were allowed to develop for four weeks. Infection status was monitored by 
taking ear punch biopsies (EPB) at seven day intervals. Ear punch biopsies were cultured in 
BSK-H media as previously described, and monitored weekly for eight weeks by darkfield 
microscopy for spirochete growth [34]. 
5.3.4. Tick Feeding 
Borrelia-free larval I. scapularis were purchased from Oklahoma State University 
Tick Laboratory and maintained in an environmental chamber (Percival, Perry IA) with a 
12:12 L:D schedule at ≥96% RH. Larval ticks were allowed to free feed until repletion on 
individual mice caged on a wire floor over water. Engorged larva from each mouse were 
allowed to molt, subjected to culture as described above, or stored in 100% ethanol at -20˚C 
until DNA extraction and qPCR could be performed. After molt, nymphal ticks were again 
subjected to culture, stored in 100% ethanol at -20˚C until DNA extraction and qPCR, or 
utilized for transmission experiments to naïve mice. 
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5.3.5 Transmission experiment  
Nymphs derived from larva fed on infected mice were utilized to determine 
transmission rates to naïve mice. After molt, ticks were allowed to rest for a minimum of two 
weeks. Again 15 mice were randomly allocated into three groups of five mice. Each mouse 
was infested with 20 nymphal I. scapularis that had previously fed on an uninfected, B. 
bissettii infected or B. burgdorferi ss infected mouse. Engorged ticks were collected and 
subjected to culture, stored in 100% ethanol at -20˚C until DNA extraction and qPCR, or 
allowed to molt to adult stage. After molt the remaining adults were subjected to culture or 
DNA extraction and qPCR. 
5.3.6. DNA Extraction and qPCR 
Whole ticks were subjected to genomic DNA extraction using GeneElute Genomic 
DNA Miniprep kit (Sigma). Ticks were minced with a sterile scalpel in separate 1.5 mL 
sterile microcentrifuge tubes containing 180 µL of Lysis Solution T (Sigma) and 20 µL of a 
20 mg/mL solution of proteinase K (Sigma). Tubes were vortexed thoroughly and placed in a 
water bath incubator at 55˚C overnight (~12 hours) until completely dissolved. Following 
incubation, gDNA extraction was carried out according to manufacturer’s supplied protocol 
except extracts were eluted in 100 µL of supplied elution buffer. Extracts were stored at -
20˚C until qPCR was performed. Borrelia-specific primers and probes for B. burgdorferi ss 
and B. bissettii were developed based on known sequences of the decorin binding protein B 
(dbpB) gene located on lp54 (a linear plasmid essential for infectivity) (Table 5.1). 17.5 µL 
of 2x Maxima Probe qPCR Master Mix (Thermo Scientific); 200nM of each Borrelia dbpB 
primer and probe combination, molecular biology grade water, and 5µL of template DNA. 
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qPCR reactions were set up in a 96-well plate in 35 µL reactions; each reaction consisted of 
From 96-well plates reactions were transferred in triplicate-10 µL aliquots to 384-well plates 
for subsequent qPCR. Standard curves for quantification were based on 10-fold serial 
dilutions (1x108 copies to 1x100 copies) of single copy gene plasmids of each Borrelia dbpB 
gene fragment. Plasmid constructs for standard curve serial dilutions were assembled 
following methods previously described [35]. Quantitative PCR was performed on a Roche 
Lightcycler 480i. Thermocycling protocol was as follows: an initial denaturation step for 10 
mins at 95˚C, followed by 40 cycles of a denaturation step for 15 sec at 95˚C and a 60 sec at 
60˚C annealing step. Analysis of reactions were conducted with the LightCycler 480i 
software. 
5.3.7. Serological Tests 
 Both western blotting and an enzyme inked immunosorbent assay were utilized to 
detect exposure to B. bissettii spirochetes in tick exposed naïve mice. To prepare whole cell 
lysates for SDS-PAGE, 10 mL of late-log page B. bissettii culture was harvested by 
centrifugation. The cell pellet was washed three times with phosphate buffered saline (PBS) 
to remove remaining media after which we added 1 mL of Laemmli Sample Buffer 
(BIORAD) with DDT. Sample was loaded into a 12% Tric-HCl precaset Ready Gel 
(BIORAD) and separated by electrophoresis using a BIORAD MINI protean tetra system 
Primer Name Sequence Reference 
BbdbpB-F 5’-GGCTAGTCCACCACTTGTTACC-3’ This Study 
BbdbpB-R 5’-GCAGCTCTTGAATCGTCCTC-3’ This Study 
BbdbpB-Probe 5’-Cy5-CACCTTTTCCCGTGGCTTCTT-3’ This Study 
BbissdbpB-F 5’-AAACGCACTCCCTTGTCAG-3’ This Study 
BbissdbpB-R 5’-GGTTGCATGTAACGTTGGAC-3’ This Study 
BbissdbpB-
Probe 
5’-HEX-TCCCTAGAAGATGATTCAAGCGC-3’ This Study 
Table 5.1. qPCR Primers and probes utilized in this study 
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(120v for 50 mins). Separated protein were then electrotransferred to a nitrocellulose 
membrane (Thermo Scientific). Membranes were blocked overnight in a 5% solution of dry 
milk (Carnation). The membrane was then transferred to a BIORAD MINI Protean 2 
multiscreen. Primary antibody, murine serum (1:50), was added to each well and incubated 
for 1 hour at room temperature (RT). After incubation serum was removed and membrane 
was washed with a solution of PBS and 0.1% Tween 20 three times for five minutes each, 
after which the seconday antibody, Alexa fluor 680 donkey anti-mouse IgG (1:15000) 
(Invitrogen), was added to each well and incubated in the dark for an additional hour. 
Membranes were then removed from the slot blot and rinse as previously mentioned. 
Membrane were visualized on a LICOR Odyssey CLx imaging system and images were 
analyzed with Image Studio Version 3.1. C6 peptide ELISA was performed as previously 
described except with murine sera diluted at 1:50 [36]. 
5.3.8. Borrelia Isolation 
Mouse tissue isolation was performed using sterilized instrument in a BSL-2 
containment cabinet. Tissues were placed in BSK-H media supplemented with antibiotics 
and monitored for growth weekly by darkfield microscopy for eight weeks [34]. Tick 
isolation was performed with media described above. Ticks were surface sterilized by 
washing in 10% bleach, phosphate buffered saline (PBS), 70% ethanol, and finally rinsed in 
molecular grade water (MO-BIO). Ticks were minced up in BSK-H with a sterile scalpel and 
monitored for spirochetal growth. 
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5.3.9. Statistical Analyses 
Mann-Whitney U tests were performed to compare spirochete burdens between tick 
infections, and a fisher’s exact test was performed to compare infection proportions. 
Statistical tests and graphs were compiled with Graphpad Prism version 5.00. p values ≤ 0.05 
were considered significantly different. 
5.4. Results 
5.4.1. Borrelia bissettii can be Acquired by I. scapularis as Successfully as B. burgdorferi ss 
but at Significantly Lower Burdens. 
 
To examine whether B. bissettii can be acquired by I. scapularis ticks, groups of 5 
C3H/HEj mice were inoculated with 106 cells of either B. burgdorferi ss or B. bissettii. Four 
weeks post-inoculation ear biopsies were taken and cultured to confirm infection. 
Approximately 200-300 I. scapularis larvae were allowed to free feed on each mouse. Upon 
detachment, ticks were surface sterilized and two tick pools (B. bissettii-infected and B. 
burgdorferi ss-infected) were generated for the entire study.  
Twenty-five engorged larva randomly selected from each pool were cultured to 
determine acquisition rates. As shown in Table 5.2, 20 of the 25 ticks from the B. burgdorferi 
ss pool were positive for spirochetes, resulting in an 80% acquisition rate. In comparison, 
cultures were grown from 16 of the 25 ticks from the B. bissettii pool; an acquisition rate of 
64% was obtained. These data allowed us to conclude that I. scapularis acquire B. bissettii as 
efficiently as B. burgdorferi ss (p = 0.35).  
Next, tick spirochete loads were determined by qPCR.  Fifty ticks were randomly 
selected from the B. bissettii infected pool and 40 ticks from the B. burgdorferi pool. 
Borrelia bissettii and B. burgdorferi were detected in 36 and 32 ticks, respectively. The 
resultant acquisition rates by qPCR were 72% for B. bissettii and 80% for B. burgdorferi (P 
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= 0.46), supporting acquisition rates as determined by culture. Ho wever, the B. burgdorferi 
spirochete load was eight times higher than that of B. bissettii (P < 0.0001) (Table 5.2).   
5.4.2. Ixodes scapularis are Unable to Transmit B. bissettii Infection to Mice.  
Engorged larvae in the two tick pools were allowed to molt to nymphs. One hundred 
randomly selected nymphs from each pool were utilized to assess the ability to transmit 
infection. Groups of 5 naïve C3H/HEj mice were each infested with 20 nymphs. Based on 
the acquisition rate determined above, each mouse had at least 12 ticks that harbored 
spirochetes. Nymphs that had fed on naïve mice were collected and pooled by Borrelia 
species infection, with each sub-pool including 100 ticks. Infection was monitored by weekly 
ear biopsies, and at 4 weeks after tick initial detachment, mice were sacrificed and tissues 
were harvested and cultured for spirochetes. As shown in Table 5.3, all mice exposed to B. 
burgdorferi ss infected ticks were infected.  In contrast, none of the mice exposed to the B. 
bissettii infected ticks had evidence of infection, indicating that I. scapularis is unable to 
transmit infection to mice. This negative finding promoted us to seek additional evidence of 
infection. As our previous study showed B. bissettii infection induced a strong anti-C6 
response in mice, we first examined this specific antibody by the C6-peptide ELISA. None of 
Murine infection 
No. of positive 
ticks/No. of ticks 
examined 
p-value Mean spirochete no./Tick p-value 
B. bissettii 16/25 
0.35 
2,305 
< 0.0001 
B. burgdorferi ss 20/25 18,467 
*Larvae were allowed to feed on mice infected with either B. bissettii or B. burgdorferi ss. 
Engorged ticks were examined for spirochete acquisition rates by culture and spirochete loads 
by qPCR. A Fisher’s exact test and Mann-Whitney U test were performed to compare 
acquisition rates and spirochete burdens, respectively.  
Table 5.2. Ixodes scapularis is able to acquire B. bissettii but generates a significant lower 
load  
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the 5 mice that were exposed to the B. bissettii-carrying ticks showed the specific response 
(data not shown), again indicating that no infection had been transmitted.  
 
Serum samples from the 5 mice exposed to B. bissettii infected nymphs were also analyzed 
by immunoblotting using whole cell lysates. As shown in Figure 5.4, only one specimen had 
a single band detected at ~33 kDa, again supporting that mice had not developed an 
infection. 
5.4.3. Ixodes scapularis is unable to support B. bissettii during its lifecycle  
The dynamics of spirochete loads was investigated throughout the I. scapularis 
developmental cycle. As described in Table 5.2, the load of B. bissettii was 8 times lower 
than that of B. burgdorferi in engorged larvae.  To investigate the next stage of the tick’s life 
cycle, 50 nymphs that had molted from engorged larvae were randomly sampled and 
spirochete burden was quantified by qPCR. Borrelia bissettii burden in unfed nymphs 
increased by 2-fold from the larval stage (P < 0.001) while B. burgdorferi burden did not 
significantly change (p > 0.05), yet had a downward trend (Figure 5.2). Spirochete burdens 
Tick inoculation 
No. of positive specimens/ no. of 
samples examined 
 
Ear 
biopsy 
Skin Heart Bladder Joint 
No. of mice 
infected/no. 
of mice 
inoculated 
B. bissettii 0/5 0/5 0/5 0/5 0/5 0/5 
B. burgdorferi ss 5/5 5/5 5/5 2/5 5/5 5/5 
Table 5.3. Ixodes scapularis is unable to transmit B. bissettii infection to mice 
*Groups of 5 mice each were inoculated with 20 nymphs that were previously collected from 
mice infected with either B. bissettii or B. burgdorferi ss. Infection was monitored by weekly 
ear biopsy. Four weeks after tick repletion mice were sacrificed and tissues were cultured for 
spirochetes. 
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between infection status significantly differed at this stage, as unfed B. burgdorferi infected 
nymphs had spirochete levels 2 times higher than B. bissettii nymphs (P < 0.001).  
When 50 engorged nymphs randomly picked from each sub-pool were analyzed, the 
most dramatic change was observed. While the B. bissettii spirochete burden showed a 
significant, albeit modest, 13% increase from unfed to engorged nymph (P < 0.0001); the 
number of B. burgdorferi spirochetes increased 45-fold (P < 0.001) after the nymphal 
bloodmeal. This resulted in engorged nymphs harboring 100 times more B. burgdorferi 
spirochetes, on average, than B. bissettii (p < 0.0001) (Figure 5.2). After nymphs molted to 
adults, B. bissetti became undetectable by qPCR, a result that was further confirmed by 
culture (data not shown), indicating the all the spirochete of this species died out during this 
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Figure 5.1. Immunoblot analysis of sera from mice exposed to B. bissettii infected nymphs. 
Four weeks after exposure to infected ticks mouse sera were diluted 1:50 and blotted against 
B. bissettii whole cell lysates for the detection of specific antibody responses. Lane 1; 
Proteins Standard Marker, Lane 2; serum from mouse infected via needle inoculation, Lanes 
3-7 sera from mice exposed to B. bissettii infected nymphs. 
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tick developmental stage. In contrast, the B. burgdorferi load remained essentially unchanged 
during this specific developmental stage (p > 0.05) (Figure 5.2).  
5.5. Discussion 
To truly understand Lyme disease is a Sisyphean task, one must understand the 
vector, the bacteria, the host, the environment and countless other unknown factors. As seen 
in the past 30 years, more and more research fuels additional questions. The United States 
harbors a diverse Borrelia fauna, and while only one species is widely believed to be 
responsible for the 300,000 human cases diagnosed annually, new evidence is challenging 
this belief. Three additional North American Lyme Borrelia spirochetes have been associated 
with human illness, some more recently than others [7, 27, 37].   
Figure 5.2. Ixodes scapularis harbors significantly less B. bissettii spirochetes than B. 
burgdorferi ss throughout the lifecycle. Whole ticks at each developmental stage were 
analyzed by qPCR to determine spirochete burdens. Data is presented as Borrelia copies of 
extracted gDNA (cegd) per tick. A Mann-Whitney U test was performed to compare between 
spirochete burdens at time points. *** P < 0.0001, ** P < 0.001. Error bars represent SEM. 
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Borrelia bissettii is a B. burgdorferi sl spirochete that has been implicated as a 
potential human disease causing agent in multiple studies [24-27]. In many respects, B. 
bissettii is very similar to the human disease causing B. burgdorferi ss spirochete. For 
example, in Europe and in many regions of the United States, both B. bissettii and B. 
burgdorferi ss geographically overlap [14, 38]. Both species have been recorded in many of 
the same hosts and ticks [13, 15, 17, 22, 39]. Infection with each species lead to similar 
infection dynamics and clinical manifestations in laboratory animal models [23]. Borrelia 
bissettii is also one of the closest related species to B. burgdorferi ss, phylogeneticaly [40]. 
Yet, unlike B. burgdorferi ss, only two tick species have been confirmed vectors for this 
group of spirochetes. In a single study, both Ixodes pacificus and Ixodes spinipalpus were 
able to acquire B. bissettii spirochetes from and transmit spirochetes to naïve dusky-footed 
woodrats and deer mice [21]. Ixodes scapularis is the common vector for many tick-borne 
pathogens including B. burgdorferi ss, throughout much of the US. Yet, its ability to 
experimentally acquire and transmit B. bissettii spirochetes remains unknown. Utilizing a 
well characterized tick-murine Borrelia infection model, we tested the hypothesis that I. 
scapularis can serve as a competent vector for B. bissettii. Unexpectedly, this was not the 
case. 
The percentage of larva that acquired spirochetes during an infectious blood meal did 
not differ between B. bissettii and B. burgdorferi ss. However, the amount of spirochetes in 
the tick post blood meal was significantly lower in B. bissettii infected ticks. Most research 
involving the exact mechanisms behind tick acquisition and transmission of Borrelia 
spirochetes have focused on B. burgdorferi ss and I. scapularis. Many B. burgdorferi ss 
genes have been shown to be involved in this part of its lifecycle [41]. While genetic 
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manipulation of these genes may impede certain aspects of tick acquisition and/or subsequent 
transmission of B. burgdorferi ss spirochetes, tick/Borrelia species compatibility is extremely 
understudied. Despite this, I. scapularis has been shown to be capable of transmitting a 
variety of geographically and genetically diverse Borrelia species and strains [42-47].  
After allowing B. bissettii infected I. scapularis to molt we assessed their ability to 
transmit B. bissettii infection to susceptible mice. While B. burgdorferi ss infected nymphs 
successfully infected all naïve mice via bloodmeal, feeding B. bissettii infected nymphs on 
naïve mice did not result in infection, as determined by culture of multiple tissues. We 
additionally utilized serology as a method of assessing infection in mice. Our previous work 
has shown B. bissettii infection in mice elicits a strong anti-C6 antibody response, yet mice 
infested with B. bissettii infected ticks showed no evidence of this specific response. 
Furthermore, immunoblots with sera form these same mice, even at low serum dilutions, 
supported the fact that B. bissettii infection was not transmitted to these mice. However, one 
mouse had evidence of a single band (~33kDa) by immunoblot indicating the potential of 
spirochete exposure. Nevertheless, cultures of engorged nymphs that had fed on naïve mice 
produced live spirochetes irrespective of Borrelia species infection. Non-competent vectors 
of B. burgdorferi ss have been demonstrated in multiple studies; however, unlike our results, 
spirochetes are often cleared shortly after larval acquisition and rarely cultivatable after molt 
[44, 45, 48, 49]. Indeed, true refractory ticks rarely have detectable bacteria even during 
infectious bloodmeals [50]. 
The detection of cultivatable spirochetes that were not transmitted in the B. bissettii 
infected I. scapularis was further explored by qPCR. We quantified the spirochete burdens in 
both infected cohorts of engorged nymphs and adults post molt. Borrelia bissettii infected 
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ticks did show modest, yet significant, increases in spirochete burdens through the ticks 
development cycle until the adult stage where evidence of spirochete infection was absent. In 
contrast, B. burgdorferi ss spirochete levels in infected ticks were not significantly different 
from acquisition to flat nymphs, however, did show a downward trend.  The most striking 
difference was the increase in spirochete burdens in the fed B. burgdorferi ss infected 
nymphs. Spirochete burdens underwent exponential increases during nymphal blood meal in 
these ticks. This was not evident in B. bissettii infected nymphs. And unlike B. bissettii 
spirochetes, B. burgdorferi ss spirochetes levels were unchanged in adult I. scapularis. At 
each developmental stage of the tick B. bissettii spirochetes levels were significantly lower 
than B. burgdorferi ss levels in infected ticks. The most dramatic difference occuring at the 
replete nymphal stage (100-fold difference). Taken together these data indicate the inability 
for I. scapularis to support the B. bissettii spirochete throughout the tick’s developmental 
cycle. 
Mice exposed to B. bissettii infected ticks did not develop infection, yet in at least one 
case a mouse showed evidence of antibodies to B. bissettii lysate by western blot, which 
could indicate exposure to live spirochetes. Utilizing immundeficient mice in future 
experiments would confirm the exposure, as spirochetes reaching the immune compromised 
host would be much more likely to establish infection. Future work could also assess for 
bacterial presence at the infected tick bite site multiple time points throughout the feeding 
period. Despite limitations in the present study we believe our description of the lack of 
exponential increase in the spirochete population in B. bissettii infected nymphs during 
feeding is an important finding. Exponential increases of spirochetes in B. burgdorferi ss 
infected nymphal midguts during feeding has been reported by others, and is hypothesized to 
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assist in traversing the tick’s midgut, a major barrier to Borrelia transmission [51, 52]. The 
lack of this exponential growth most likely played a factor in I. scapularis’ inability to 
transmit B. bissettii to susceptible mice. However, the overall lower spirochete burdens in B. 
bissettii infected ticks at all stages indicates multiple factors may contribute to the tick’s 
inability to transmit this spirochete. The lack of transmission in our study suggests B. bissettii 
enzootic cycles in the eastern and southern US may rely on a different tick vector. One 
possibility is the Ixodes affinis tick. These ticks have been described along the eastern and 
southern US and contribute to enzootic cycles of B. burgdorferi ss in these areas [22, 53-57]. 
Furthermore, at least one study has detected B. bissettii in these ticks however, this area 
remains understudied [58]. 
Assessing the vector competence of newly described Borrelia species should be an 
area of continued study, especially now that the Lyme Borrelia complex is expanding, and 
more and more species are being associated with human illness. We describe an interesting 
finding while assessing the ability of I. scapularis to transmit B. bissettii. While it appears 
that multiple factors may contribute to our observation that B. bissettii infected ticks are 
unable to transmit infection to susceptible hosts, the exact mechanisms behind this require 
further studies. We believe this “transmissionless” tick infection model may provide 
important information into the Borrelia-tick interface. With the advent of technologies like 
next generation sequencing and advanced microscopy techniques, this unique model may 
provide an important glimpse into questions of Borrelia vector competence. 
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CHAPTER 6. DISCUSSION OF RESULTS AND FUTURE RESEARCH DIRECTION 
6.1. Discussion 
 Lyme borreliosis is responsible for an estimated 300,000 cases of human illness 
annually in the United States [1]. Since the discovery of Borrelia burgdorferi, thirty years of 
research has led to an exceptional expansion of the Lyme Borrelia species complex. Each 
new discovery and description increases the complexity of this epidemic. Currently a total of 
19 Lyme Borrelia species are recognized worldwide [2]. The United States harbors a diverse 
fauna of Lyme Borrelia spirochetes. Seven species have been described in the US; however, 
only one, B. burgdorferi ss, is widely considered responsible for cases of human Lyme 
borreliosis [3, 4]. Evidence is coming forward that implicates other species in human illness, 
yet the research into these organism remains infantile [5, 6]. Areas of the US reporting the 
majority of the human Lyme borrelisosis cases are hyperendmic for the B. burgdorferi ss 
spirochete and its vector tick, Ixodes scapularis [7]. Not consequently these are the causative 
agent and vector for the majority of human illness. However, areas not considered endemic 
for the spirochete can harbor large populations of the vector. Louisiana continually reports 
sporadic cases of human borreliosis yet investigation into the presence of Lyme Borrelia 
have not been conducted [8].  
 We conducted general molecular surveys investigating bacterial pathogens in known 
human biting ticks in Louisiana, an understudied state. Detection of bacterial pathogens in 
their respective vectors was not unexpected. We present the first report of two known tick-
borne zoonoses in their vectors: B. burgdorferi ss in Ixodes scapularis and Rickettsia parkeri 
in Amblyomma maculatum [9]. We also report the first detection of Borrelia bissettii in 
Louisiana this was detected in an Amblyomma americanum, this tick is not a known vector 
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for Lyme Borrelia and given the fact it was collected off a host this may indicate B. bissettii 
infection in the bear. Detection of Lyme Borrelia in I. scapularis was further corroborated 
with field studies in Tunica Hills, Louisiana [10]. Tunica hills supports large populations of 
wildlife and multiple tick species. The successful detection of B. burgdorferi ss in I. 
scapularis adults and in known animal reservoirs at this site should be further investigated 
with larger studies across the state. While Louisiana is similar to most southern states in that 
only sporadic cases of human Lyme borreliosis are reported each year, we should not 
undermine the fact that locally acquired infections do occur [11]. Nymphal I. scapularis are 
the vector most commonly associated with human Lyme borreliosis cases in hyperendemic 
regions of the US [12]. In southern states, including Louisiana, it is rare to encounter this life 
stage of the tick. However, adult I. scapularis are competent Lyme Borrelia vectors and 
should not be overlooked as a human health threat. At Tunica Hills, I. scapularis are infected 
with B. burgdorferi ss at rates far lower than areas in the US were the majority of human 
Lyme cases are reported, but at rates consistent with other southern states. Obviously the risk 
of contracting Lyme disease in Louisiana is not as high as other areas in the US. Nevertheless 
the risk is still present and the diagnosis and subsequent treatment of infection requires 
knowledge of the presence of the pathogen in vectors. Lyme borreliosis is becoming more 
and more common in areas once considered devoid of the bacteria and tick [13, 14]. Reasons 
behind this “spread” are still a topic of debate; however monitoring the presence of vector 
borne diseases should be a top priority in areas where large populations of the vectors are 
present. Until a fool-proof method to protect against Lyme Borrelia infections is discovered, 
the approximately 300,000 cases of human Lyme disease diagnosed annually is steadily 
going to increase. 
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 Of the seven North American Lyme Borrelia spirochetes, only B. burgdorferi ss is 
consistently studied. Borrelia burgdorferi ss is the purported spirochete behind all 300,000 
annual cases of human Lyme borreliosis in the US. Yet, more and more people are getting 
infected in areas where the vector rarely encounters humans and where the pathogen is either 
not found or not yet detected [8]. Many of these regions do harbor many other Lyme Borrelia 
spirochetes whose human pathogenic status remains unknown. Borrelia bissettii is an 
understudied Borrelia spirochete that in many ways is very similar to B. burgdorferi ss. We 
analyzed the infection of this spirochete in a murine model. Our results corroborate and 
expand upon the few studies utilizing this spirochete [15, 16]. We report the similarities 
between infection with B. bissettii and B. burgdorferi ss in the mouse. Spirochete infection 
burdens support murine pathology reported by others and substantiate the few reports of this 
bacteria being detected in human clinical samples. Most importantly, we describe the murine 
humoral response to B. bissettii infection, reporting the cross reactivity of two common 
serological Lyme diagnostic assays. Over 3.4 million Lyme tests are performed each year in 
the US at an estimated cost of almost $500 million [17]. Other species like B. bissettii may be 
pathogenic to humans and present identical in Lyme diagnostic tests. Could the range of 
pathogenic Lyme Borrelia endemic areas be much larger than we realize?  Further studies 
should focus on investigating non-B. burgdorferi ss Borrelia spirochetes and their potential 
to cause mammalian disease and cross reactivity with current Lyme diagnostic tests. 
We report the first whole genome shotgun sequence of an infectious isolate of B. 
bissettii. The homology shared between B. bissettii and B. burgdorferi ss virulence genes 
support the infectious phenotype described in our murine model. The advent of next 
generation sequence technologies allows us to do comparative genomics between infectious 
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and non-infectious Borrelia species, yet many species still remain poorly characterized. 
Sequencing of representative Borrelia species would be of great benefit to the field. 
 The geographical overlap of B. bissettii and B. burgdorferi ss is very peculiar. Both 
are regularly detected in similar hosts and ticks, including the common B. burgdorferi vector 
(I. scapularis) [4, 18]. Yet vector competence of I. scapularis for the B. bissettii spirochete 
has not been demonstrated. We assessed the ability for I. scapularis to acquire and transmit 
the B. bissettii spirochete to susceptible mice. Our results indicate that I. scapularis, while 
susceptible to B. bissettii infection, is not capable of transmitting infection to naive mice. 
And while serological tests confirmed the inability to cause infection, one animal did had a 
single reactive band by western blot indicating exposure may have occurred, however, this 
band was only evident in highly concentrated sera in only one animal, which lends evidence 
to a potential non-specific cross reaction. Spirochete burdens throughout the tick’s lifecycle 
are significantly lower in B. bissettii infections and absent in the adult. Borrelia bissettii fails 
to start replicating upon initiation of the nymphal blood meal, a trait important for successful 
transmission from B. burgdorferi ss infected ticks to susceptible animals [19]. These data 
indicate that another tick is most likely responsible for B. bissettii enzootic cycles in eastern 
and southern areas of the US. Although two species of ticks in the western US have been 
determined competent vectors for B. bissettii, future work should investigate the vector 
competence of other tick species in the eastern US [15]. The ability of I. scapularis to acquire 
B. bissettii, yet not transmit the organism, could facilitate more in depth studies on 
tick/Borrelia compatibility. Because of the genetic similarities between B. burgdorferi ss and 
B. bissettii deep sequencing technologies like RNA-Seq may successfully identify pan 
genomic differences between the two organisms throughout stages of tick infection.  
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The inability of I. scapulairs in this work to transmit B. bissettii infection to 
susceptible animals is confounding as the spirochete has been detected in both rodents and 
ticks in molecular surveys [20, 21]. One explanation for this is that there may be a cryptic 
vector of B bissettii in the eastern and southern US. Indeed, the nidicoulus Ixodes affinis has 
been found to be infected with B. bissettii [22]. Future work should assess the competency of 
ticks such as I. affinis. Another explanation to our finding is that our isolate was a Colorado 
isolate of B. bissettii, eastern and southern isolates of B. bissettii may differ. While this may 
be true, robust genetic analysis of B. bissettii in the Western and Eastern US have reliably 
concluded they are of the same species [23, 24]. And while one may argue that geographical 
isolation of the species may lead to strict vector association; this is not the case with other 
species of Lyme Borrelia and ticks [25, 26]. Future work should be done to tease out the 
unique mechanisms seen in this I. scapularis-B. bissettii-murine model. 
 In conclusion, this dissertation describes novel distributions of tick-borne bacterial 
pathogens in Louisiana, mainly Borrelia burgdorferi ss. It also assesses the pathogenic 
potential of the spirochete Borrelia bissettii, more specifically identifying similarities with 
Borrelia burgdorferi ss in a murine model. This is also the first evidence describing the cross 
reactivity of the C6-Peptide ELISA Lyme diagnostic test to a North American non-B. 
burgdorferi ss infection. We report the first whole genome shotgun sequence of an infectious 
North American non-B. burgdorferi ss spirochete. We lastly describe a peculiar tick/Borrelia 
interaction: the ability of I. scapularis to acquire but not transmit B. bissettii infection to 
susceptible mice. 
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